Amedeo Smart

Free Medical Literature Service

 

Amedeo

HIV Infection
  Free Subscription

Articles published in
J Acquir Immune Defic Syndr
    May 2024

  1. Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study): Erratum.
    J Acquir Immune Defic Syndr. 2024;96:e3.
    >> Share

  2. RAMBIKI E, Rambiki K, Khalani J, Huwa J, et al
    Letters to the Editor Low Rates of Side Effects in Paclitaxel Chemotherapy for Kaposi Sarcoma and Feasibility of Treatment in Outpatient ART Clinic Settings in Malawi.
    J Acquir Immune Defic Syndr. 2024;96:e1-e2.
    >> Share

    April 2024
  3. DORWARD J, Sookrajh Y, Lessells R, Bulo E, et al
    Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2024;95:e8-e11.
    >> Share

  4. KABAMI J, Koss CA, Sunday H, Biira E, et al
    Randomized Trial of Dynamic Choice HIV Prevention at Antenatal and Postnatal Care Clinics in Rural Uganda and Kenya.
    J Acquir Immune Defic Syndr. 2024;95:447-455.
    >> Share

  5. YOUNGUI BT, Atwine D, Otai D, Vasiliu A, et al
    Integration of HIV Testing in a Community Intervention for Tuberculosis Screening Among Household Contacts of Patients with Tuberculosis in Cameroon and Uganda.
    J Acquir Immune Defic Syndr. 2024;95:431-438.
    >> Share

  6. SHADE SB, Gutin SA, Agnew E, Grignon JS, et al
    Cost Analysis of Short Messaging Service and Peer Navigator Interventions for Linking and Retaining Adults Recently Diagnosed With HIV in Care in South Africa.
    J Acquir Immune Defic Syndr. 2024;95:417-423.
    >> Share

  7. FU W, McClymont E, Av-Gay G, Dorling M, et al
    Retrospective Cohort Study on the Impact of the COVID-19 Pandemic on Pregnancy Outcomes for Women Living With HIV in British Columbia.
    J Acquir Immune Defic Syndr. 2024;95:411-416.
    >> Share

  8. MOAWAD MHED, Mohamed Shalaby MM, Hamouda E, Mahfouz A, et al
    Risk of Stroke Among HIV Patients: A Systematic Review and Meta-analysis of Global Studies and Associated Comorbidities.
    J Acquir Immune Defic Syndr. 2024;95:399-410.
    >> Share

  9. ERENRICH RK, Braun RA, Torres-Mendoza DM, Stevenson OL, et al
    Effectiveness of PrEPTECH: Findings From a 180-Day Randomized Controlled Trial of a Pre-Exposure Prophylaxis Telehealth Intervention.
    J Acquir Immune Defic Syndr. 2024;95:463-469.
    >> Share

  10. ERLY S, Menza TW, Granillo L, Navejas M, et al
    Impact of COVID-19 on People Living with HIV: Data from Five Medical Monitoring Project Sites, 2020-2022.
    J Acquir Immune Defic Syndr. 2024 Apr 2. doi: 10.1097/QAI.0000000000003403.
    >> Share

  11. KENNEDY CE, Yeh PT, Verster A, Luhmann N, et al
    Do Peer Navigators Improve Initiation and Retention in HIV/VH/STI Treatment Programs for People From Key Populations? A Systematic Review of Effectiveness, Values and Preferences, and Cost.
    J Acquir Immune Defic Syndr. 2024;95:305-312.
    >> Share

  12. VOLK JE, Leyden WA, Lea AN, Lee C, et al
    Using Electronic Health Records to Improve HIV Preexposure Prophylaxis Care: A Randomized Trial.
    J Acquir Immune Defic Syndr. 2024;95:362-369.
    >> Share

  13. FRANCE AM, Panneer N, Farnham PG, Oster AM, et al
    Simulation of Full HIV Cluster Networks in a Nationally Representative Model Indicates Intervention Opportunities.
    J Acquir Immune Defic Syndr. 2024;95:355-361.
    >> Share

  14. LOGAN NZ, Kilmarx PH, Rolle I, Patel HK, et al
    Brief Report: Self-Reported HIV-Positive Status but Subsequent HIV-Negative Test Results in Population-Based HIV Impact Assessment Survey Participants-11 Sub-Saharan African Countries, 2015-2018.
    J Acquir Immune Defic Syndr. 2024;95:313-317.
    >> Share

    March 2024
  15. HICKEY MD, Grochowski J, Mayorga-Munoz F, Oskarsson J, et al
    Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People with HIV Who Are Virally Unsuppressed.
    J Acquir Immune Defic Syndr. 2024 Mar 27. doi: 10.1097/QAI.0000000000003421.
    >> Share

  16. LINNEMAYR S, Wagner Z, Saya UY, Stecher C, et al
    Behavioral economic incentives to support HIV care: Results from a randomized controlled trial in Uganda.
    J Acquir Immune Defic Syndr. 2024 Mar 27. doi: 10.1097/QAI.0000000000003420.
    >> Share

  17. QIAN Y, Zhang P, Wang L, Suo J, et al
    The association of intraocular efavirenz concentrations and HIV-1 viral load among persons with HIV.
    J Acquir Immune Defic Syndr. 2024 Mar 25. doi: 10.1097/QAI.0000000000003426.
    >> Share

  18. BUNTING SR, Feinstein BA, Vidyasagar N, Sheth NK, et al
    Psychiatry and Family Medicine Residents' Likelihood of Prescribing HIV Pre-Exposure Prophylaxis (PrEP) to Patients with Mental Illness and HIV Vulnerability.
    J Acquir Immune Defic Syndr. 2024 Mar 25. doi: 10.1097/QAI.0000000000003423.
    >> Share

  19. PATEL D, Williams WO, Wright C, Essuon A, et al
    CDC-Funded HIV Testing and Undiagnosed HIV Infection in Ending the HIV Epidemic in the U.S. Jurisdictions.
    J Acquir Immune Defic Syndr. 2024 Mar 23. doi: 10.1097/QAI.0000000000003424.
    >> Share

  20. WEISER J, Tie Y, Crim SM, Riedel DJ, et al
    Do HIV Care Outcomes Differ by Provider Type?
    J Acquir Immune Defic Syndr. 2024 Mar 7. doi: 10.1097/QAI.0000000000003410.
    >> Share

  21. MADLALA HP, Myer L, Geffen H, Rusch J, et al
    Inflammatory markers in pregnancy are associated with postpartum weight in South African women living with HIV on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2024 Mar 4. doi: 10.1097/QAI.0000000000003406.
    >> Share

  22. NUNEZ I, Ceballos-Liceaga SE, Torre A, Garcia-Rodriguez G, et al
    Clinical features and outcomes of mpox in people with and without HIV: a national comparative study.
    J Acquir Immune Defic Syndr. 2024 Mar 4. doi: 10.1097/QAI.0000000000003407.
    >> Share

  23. HANLEY S, Moodley D, Naidoo M, Brummel SS, et al
    THE IMPACT OF REGULAR SCREENING AND LIFESTYLE MODIFICATION ON CARDIOVASCULAR DISEASE RISK FACTORS IN SOUTH AFRICAN WOMEN LIVING WITH HIV.
    J Acquir Immune Defic Syndr. 2024 Mar 1. doi: 10.1097/QAI.0000000000003387.
    >> Share

  24. OBOHO IK, Esber AL, Dear N, Paulin HN, et al
    Advanced HIV Disease in East Africa and Nigeria, in The African Cohort Study (AFRICOS).
    J Acquir Immune Defic Syndr. 2024 Mar 1. doi: 10.1097/QAI.0000000000003392.
    >> Share

  25. BEN FARHAT J, TiendrebeogoMD T, Malateste K, Poda A, et al
    Effects of the Covid-19 pandemic on ART initiation and access to HIV viral load monitoring in adults living with HIV in West Africa: a regression discontinuity analysis.
    J Acquir Immune Defic Syndr. 2024 Mar 1. doi: 10.1097/QAI.0000000000003404.
    >> Share

  26. TANAKA T, Oshima K, Kawano K, Tashiro M, et al
    Nationwide Longitudinal Annual Survey of HIV/AIDS Referral Hospitals in Japan From 1999-2021: Trend in Non-AIDS-Defining Cancers Among HIV-1-Infected Individuals.
    J Acquir Immune Defic Syndr. 2024 Mar 1. doi: 10.1097/QAI.0000000000003389.
    >> Share

  27. CALZA L, Giglia M, Viale P
    Relationship Between Vitamin D Deficiency and Nonalcoholic Fatty Liver Disease in Patients With HIV-1 Infection.
    J Acquir Immune Defic Syndr. 2024;95:e5-e7.
    >> Share

  28. MCCRARY AW, Hung F, Foster MC, Koech M, et al
    Letter to the Editor: Cardiac Dysfunction Among Youth With Perinatal HIV Acquisition and Exposure.
    J Acquir Immune Defic Syndr. 2024;95:e2-e4.
    >> Share

  29. NABUKALU D, Yiannoutsos CT, Semeere A, Musick BS, et al
    Mortality Among HIV-Infected Adults on Antiretroviral Therapy in Southern Uganda.
    J Acquir Immune Defic Syndr. 2024;95:268-274.
    >> Share

  30. VAN HEERDEN JK, Meintjes G, Barr D, Zhao Y, et al
    Relationship Between Tenofovir Diphosphate Concentrations in Dried Blood Spots and Virological Outcomes After Initiating Tenofovir-Lamivudine-Dolutegravir as First-Line or Second-Line Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2024;95:260-267.
    >> Share

  31. NGUMBAU NM, Neary J, Wagner AD, Abuna F, et al
    Cofactors of Partner HIV Self-testing and Oral PrEP Acceptance Among Pregnant Women at High Risk of HIV in Kenya.
    J Acquir Immune Defic Syndr. 2024;95:238-245.
    >> Share

    February 2024
  32. GRIESEL R, Banda CG, Zhao Y, Omar Z, et al
    PHARMACOKINETICS OF SINGLE VERSUS DOUBLE-DOSE DOLUTEGRAVIR AFTER SWITCHING FROM A FAILING EFAVIRENZ-BASED REGIMEN.
    J Acquir Immune Defic Syndr. 2024 Feb 15. doi: 10.1097/QAI.0000000000003402.
    >> Share

  33. WANDIKA B, Nyapara F, Aballa C, Richardson BA, et al
    Lower self-reported ART adherence among adolescents in boarding schools compared to day schools.
    J Acquir Immune Defic Syndr. 2024 Feb 12. doi: 10.1097/QAI.0000000000003400.
    >> Share

  34. WELD ED, Ogasawara K, Fuchs EJ, Louissaint N, et al
    Mapping Colorectal Distribution of Cell-free and Cell-associated HIV Surrogates Following Simulated Anal Intercourse to Aid Rectal Microbicide Development.
    J Acquir Immune Defic Syndr. 2024 Feb 12. doi: 10.1097/QAI.0000000000003401.
    >> Share

  35. RICHTERMAN A, Sinha P, Ivers LC, Gross R, et al
    Food Insecurity and Undernutrition are Associated with Distinct Immunologic Profiles in People with Tuberculosis and Advanced HIV Starting Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2024 Feb 12. doi: 10.1097/QAI.0000000000003386.
    >> Share

  36. STONER MCD, Smith L, Ming K, Mancuso N, et al
    Results from a pilot study of an automated directly observed therapy intervention using artificial intelligence with conditional economic incentives among young adults with HIV.
    J Acquir Immune Defic Syndr. 2024 Feb 8. doi: 10.1097/QAI.0000000000003397.
    >> Share

  37. DE WIT S, Bonnet F, Osiyemi O, Bisshop F, et al
    Durable Efficacy of Switching From a 3- or 4-Drug Tenofovir Alafenamide-Based Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine in the TANGO Study Through Week 196.
    J Acquir Immune Defic Syndr. 2024 Feb 8. doi: 10.1097/QAI.0000000000003395.
    >> Share

  38. MEHTANI NJ, Strough A, Strieff S, Zevin B, et al
    Feasibility of Implementing a Low-Barrier Long-Acting Injectable Antiretroviral Program for HIV Treatment & Prevention for People Experiencing Homelessness.
    J Acquir Immune Defic Syndr. 2024 Feb 8. doi: 10.1097/QAI.0000000000003396.
    >> Share

  39. OZKAYA HD, Elazab K, Turan B, Nazli A, et al
    Missed opportunities in HIV testing in Turkiye: Implications for late diagnoses.
    J Acquir Immune Defic Syndr. 2024 Feb 8. doi: 10.1097/QAI.0000000000003398.
    >> Share

  40. OPSTEEN S, Fram T, Files JK, Levitan EB, et al
    Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2.
    J Acquir Immune Defic Syndr. 2024 Feb 8. doi: 10.1097/QAI.0000000000003399.
    >> Share

  41. MACHAVARIANI E, Miceli J, Altice FL, Fanfair RN, et al
    Using Data-to-Care Strategies to Optimize the HIV Care Continuum in Connecticut: Results from a Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2024 Feb 7. doi: 10.1097/QAI.0000000000003391.
    >> Share

  42. REIS K, Wolf A, Perumal R, Seepamore B, et al
    Differentiated service delivery framework for people with multidrug-resistant tuberculosis and HIV co-infection.
    J Acquir Immune Defic Syndr. 2024 Feb 6. doi: 10.1097/QAI.0000000000003394.
    >> Share


  43. Social Factors Associated With Trajectories of HIV-Related Stigma and Everyday Discrimination Among Women Living With HIV in Vancouver, Canada: Longitudinal Cohort Findings: Erratum.
    J Acquir Immune Defic Syndr. 2024;95:e1.
    >> Share


  44. Increasing Spiritual Beliefs are Associated With Lower HIV Incidence Among Black Men Who Have Sex With Men: Results From HPTN 061 Longitudinal Study: Erratum.
    J Acquir Immune Defic Syndr. 2024;95:e1.
    >> Share

  45. GRASSI G, Notari S, Cicalini S, Casetti R, et al
    Brief Report: In cART-Treated HIV-Infected Patients, Immunologic Failure Is Associated With a High Myeloid-Derived Suppressor Cell Frequency.
    J Acquir Immune Defic Syndr. 2024;95:185-189.
    >> Share

  46. DAVIDOVIC M, Asangbeh SL, Taghavi K, Dhokotera T, et al
    Facility-Based Indicators to Manage and Scale Up Cervical Cancer Prevention and Care Services for Women Living With HIV in Sub-Saharan Africa: a Three-Round Online Delphi Consensus Method.
    J Acquir Immune Defic Syndr. 2024;95:170-178.
    >> Share

  47. ATTOH-OKINE ND, Corbeil T, Poku O, Kluisza L, et al
    Prevalence and Correlates of Intimate Partner Violence Victimization Among Urban Adolescents and Young Adults Living With Perinatally-Acquired HIV Infection or Perinatal HIV Exposure.
    J Acquir Immune Defic Syndr. 2024;95:107-116.
    >> Share


  48. Delivery of Community-Based Antiretroviral Therapy to Maintain Viral Suppression and Retention in Care in South Africa: Erratum.
    J Acquir Immune Defic Syndr. 2024;95:e1.
    >> Share

    January 2024
  49. POKU O, Attoh-Okine ND, Corbeil T, Chen Y, et al
    Assessing the Validity of the Social Impact Scale Among a Longitudinal Cohort of Adolescents and Young Adults Living with Perinatally-Acquired HIV.
    J Acquir Immune Defic Syndr. 2024 Jan 24. doi: 10.1097/QAI.0000000000003390.
    >> Share

  50. TURK T, Labarile M, Braun DL, Rauch A, et al
    CHARACTERIZATION AND DETERMINANTS OF LONG-TERM IMMUNE RECOVERY UNDER SUPPRESSIVE ANTIRETROVIRAL THERAPY.
    J Acquir Immune Defic Syndr. 2024 Jan 24. doi: 10.1097/QAI.0000000000003388.
    >> Share

  51. NGUYEN VT, Nagavedu K, Morrison M, Chen T, et al
    COVID-19 Severity in People with HIV Compared to Those Without HIV.
    J Acquir Immune Defic Syndr. 2024 Jan 15. doi: 10.1097/QAI.0000000000003378.
    >> Share

  52. SPECTOR SA, Brummel SS, Chang A, Wiznia A, et al
    Impact of Genetic Variants in ABCG2, NR1I2 and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children.
    J Acquir Immune Defic Syndr. 2024 Jan 3. doi: 10.1097/QAI.0000000000003358.
    >> Share

  53. MEDINA-JAUDES N, Adoa D, Williams A, Amulen C, et al
    Predicting lost to follow-up status using an adolescent HIV psychosocial attrition risk assessment tool: Results from a mixed methods prospective cohort study in Uganda.
    J Acquir Immune Defic Syndr. 2024 Jan 2. doi: 10.1097/QAI.0000000000003381.
    >> Share

  54. ABIDI MZ, Umbleja T, Overton ET, Burdo T, et al
    CMV IgG is Associated with Physical Function but not Muscle Density in People with HIV.
    J Acquir Immune Defic Syndr. 2024 Jan 2. doi: 10.1097/QAI.0000000000003377.
    >> Share

  55. ABELMAN RA, Schneider MF, Cox C, Messerlian G, et al
    ASSOCIATION OF ANDROGEN HORMONES, SEX HORMONE BINDING GLOBULIN, AND THE MENOPAUSAL TRANSITION WITH INCIDENT DIABETES MELLITUS IN WOMEN WITH AND WITHOUT HIV.
    J Acquir Immune Defic Syndr. 2024 Jan 2. doi: 10.1097/QAI.0000000000003380.
    >> Share

  56. BUNGE K, Balkus JE, Fairlie L, Mayo AJ, et al
    DELIVER: A Safety Study of a Dapivirine Vaginal Ring and Oral PrEP for the Prevention of HIV During Pregnancy.
    J Acquir Immune Defic Syndr. 2024;95:65-73.
    >> Share

  57. AYIEKO J, Balzer LB, Inviolata C, Kakande E, et al
    Randomized Trial of a "Dynamic Choice" Patient-Centered Care Intervention for Mobile Persons With HIV in East Africa.
    J Acquir Immune Defic Syndr. 2024;95:74-81.
    >> Share

  58. YIGIT I, Turan B, Kurt G, Weiser SD, et al
    Longitudinal Associations of Experienced and Perceived Community Stigma with ART Adherence and Viral Suppression in New-to-care People with HIV: Mediating Roles of Internalized Stigma and Depression Symptoms.
    J Acquir Immune Defic Syndr. 2024 Jan 1. doi: 10.1097/QAI.0000000000003360.
    >> Share

  59. ALLORANT A, Muset P, Hodgins C, Kirakoya-Samadoulougou F, et al
    Temporal Trends and Determinants of HIV Testing at Antenatal Care in Sub-Saharan Africa: A Pooled Analysis of Population-Based Surveys (2005-2021).
    J Acquir Immune Defic Syndr. 2024;95.
    >> Share

  60. BROWN T, Peerapatanapokin W, Siripong N, Puckett R, et al
    The AIDS Epidemic Model 2023 for Estimating HIV Trends and Transmission Dynamics in Asian Epidemic Settings.
    J Acquir Immune Defic Syndr. 2024;95.
    >> Share

  61. TRICKEY A, Glaubius R, Pantazis N, Zangerle R, et al
    Estimation of Improvements in Mortality in Spectrum Among Adults With HIV Receiving Antiretroviral Therapy in High-Income Countries.
    J Acquir Immune Defic Syndr. 2024;95.
    >> Share

  62. GLAUBIUS R, Stover J, Johnson LF, Mahiane SG, et al
    Differences in Breastfeeding Duration by Maternal HIV Status: A Pooled Analysis of Nationally Representative Surveys in Sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2024;95.
    >> Share

  63. STEVENS O, Boothe M, Tiberi O, Mahy M, et al
    Triangulation of Routine Antenatal HIV Prevalence Data and Adjusted HIV Estimates in Mozambique.
    J Acquir Immune Defic Syndr. 2024;95.
    >> Share

  64. SILHOL R, Anderson RL, Stevens O, Stannah J, et al
    Measuring HIV Acquisitions Among Partners of Key Populations: Estimates From HIV Transmission Dynamic Models.
    J Acquir Immune Defic Syndr. 2024;95.
    >> Share

  65. STEVENS O, Anderson R, Stover J, Teng Y, et al
    Comparison of Empirically Derived and Model-Based Estimates of Key Population HIV Incidence and the Distribution of New Infections by Population Group in Sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2024;95.
    >> Share

  66. KORENROMP EL, Sabin K, Stover J, Brown T, et al
    New HIV Infections Among Key Populations and Their Partners in 2010 and 2022, by World Region: A Multisources Estimation.
    J Acquir Immune Defic Syndr. 2024;95.
    >> Share

  67. ESRA R, Mmelesi M, Ketlogetswe AT, Wolock TM, et al
    Improved Indicators for Subnational Unmet Antiretroviral Therapy Need in the Health System: Updates to the Naomi Model in 2023.
    J Acquir Immune Defic Syndr. 2024;95.
    >> Share

  68. STOVER J, Glaubius R
    Methods and Assumptions for Estimating Key HIV Indicators in the UNAIDS Annual Estimates Process.
    J Acquir Immune Defic Syndr. 2024;95.
    >> Share

  69. VAN SCHALKWYK C, Mahy M, Johnson LF, Imai-Eaton JW, et al
    Updated Data and Methods for the 2023 UNAIDS HIV Estimates.
    J Acquir Immune Defic Syndr. 2024;95.
    >> Share

    December 2023
  70. JONES R, Jessee MB, Booker R, Martin SL, et al
    Associations between Estimates of Arterial Stiffness and Cognitive Functioning in Adults with HIV.
    J Acquir Immune Defic Syndr. 2023 Dec 22. doi: 10.1097/QAI.0000000000003374.
    >> Share

  71. KEDDEM S, Thatipelli S, Caceres O, Roder N, et al
    Barriers and Facilitators to Long-Acting Injectable HIV PrEP Implementation in Primary Care Since Its Approval in the United States.
    J Acquir Immune Defic Syndr. 2023 Dec 22. doi: 10.1097/QAI.0000000000003370.
    >> Share

  72. KIM TW, Bertholet N, Magane KM, Lloyd-Travaglini C, et al
    Alcohol consumption and illicit drug use: associations with fall, fracture, and acute healthcare utilization among people with HIV infection.
    J Acquir Immune Defic Syndr. 2023 Dec 22. doi: 10.1097/QAI.0000000000003372.
    >> Share

  73. RAMAKRISHNAN A, Fujita AW, Mehta CC, Wilson TE, et al
    Substance Use Care Continuum in Women with and without HIV in the Southern United States.
    J Acquir Immune Defic Syndr. 2023 Dec 22. doi: 10.1097/QAI.0000000000003373.
    >> Share

  74. RAMIREZ-ORTIZ D, Jean-Gilles M, Sheehan DM, Ladner R, et al
    Factors Associated with COVID-19 Vaccination among Racial/Ethnic Minority Groups with HIV in South Florida.
    J Acquir Immune Defic Syndr. 2023 Dec 22. doi: 10.1097/QAI.0000000000003369.
    >> Share

  75. BYRD KK, Buchacz K, Crim SM, Beer L, et al
    Unmet needs for HIV ancillary services among persons with diagnosed HIV aged 55 years and older.
    J Acquir Immune Defic Syndr. 2023 Dec 22. doi: 10.1097/QAI.0000000000003365.
    >> Share

  76. RILEY ED, Vittinghoff E, Ravi A, Coffin PO, et al
    The role of substance use in structural heart disease among women living with HIV.
    J Acquir Immune Defic Syndr. 2023 Dec 19. doi: 10.1097/QAI.0000000000003366.
    >> Share

  77. THOMAS D, Nakabugo L, Nambi F, Kibuuka J, et al
    Intimate partner violence and adherence to PrEP and ART among Ugandan HIV serodifferent couples.
    J Acquir Immune Defic Syndr. 2023 Dec 19. doi: 10.1097/QAI.0000000000003368.
    >> Share

  78. BROOKS KM, Pau AK, Swaim D, Bunn HT, et al
    Pharmacokinetics, Safety, and Tolerability of Once-Daily Darunavir With Cobicistat and Weekly Isoniazid/Rifapentine.
    J Acquir Immune Defic Syndr. 2023;94:468-473.
    >> Share

  79. KHOURI A, Stephens MJ, Young J, Galyean P, et al
    Cancer Treatment Decision-Making for People Living With HIV: Physician-Reported Barriers, Facilitators, and Recommendations.
    J Acquir Immune Defic Syndr. 2023;94:482-489.
    >> Share

  80. MOTTA F, Milic J, Gozzi L, Belli M, et al
    A Machine Learning Approach to Predict Weight Change in ART-Experienced People Living With HIV.
    J Acquir Immune Defic Syndr. 2023;94:474-481.
    >> Share

  81. O'HALLORAN JA, Parra-Rodriguez L, Goss CW, Agarwal M, et al
    Impact of Integrase Strand Transfer Inhibitors on Cognition in the HAILO Cohort.
    J Acquir Immune Defic Syndr. 2023;94:437-444.
    >> Share

  82. HUMPHREY J, Wanjama E, Carlucci JG, Naanyu V, et al
    Preferences of Pregnant and Postpartum Women for Differentiated Service Delivery in Kenya.
    J Acquir Immune Defic Syndr. 2023;94:429-436.
    >> Share

  83. JOHNSON AL, Butts SA, Rodriguez E, Craker L, et al
    "Test-To-PrEP": Assessing Reach and Adoption of a New Approach to Increase HIV Testing and PrEP Knowledge Using HIV Self-Test Kit Distribution Through PrEP Clients' Social Networks.
    J Acquir Immune Defic Syndr. 2023;94:421-428.
    >> Share

  84. FAIRLIE L, Sawry S, Pals S, Sherman G, et al
    More Frequent HIV Viral Load Testing With Point-Of-Care Tests Detects Elevated Viral Load Earlier in Postpartum HIV-Positive Women in a Randomized Controlled Trial in Two Clinics in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2023;94:412-420.
    >> Share

  85. WIEHE SE, Nelson TL, Aalsma MC, Rosenman MB, et al
    HIV Care Continuum Among People Living With HIV and History of Arrest and Mental Health Diagnosis.
    J Acquir Immune Defic Syndr. 2023;94:403-411.
    >> Share

  86. JACKSON H, Dunphy C, Grist MB, Jiang X, et al
    Weathering the Storm: Syringe Services Program Laws and Human Immunodeficiency Virus During the COVID-19 Pandemic.
    J Acquir Immune Defic Syndr. 2023;94:395-402.
    >> Share

  87. NYANDIKO W, Enjema NA, Mugo R, Apondi E, et al
    PREDICTORS OF MORTALITY AMONG CHILDREN AND ADOLESCENTS LIVING WITH HIV ON ANTIRETROVIRAL THERAPY IN WESTERN KENYA.
    J Acquir Immune Defic Syndr. 2023 Dec 15. doi: 10.1097/QAI.0000000000003361.
    >> Share

  88. OLIVEIRA VH, Willig AL, Davey CH, Buford TW, et al
    Relationship between adiposity and biomarkers of aging and frailty among adults aging with HIV.
    J Acquir Immune Defic Syndr. 2023 Dec 14. doi: 10.1097/QAI.0000000000003362.
    >> Share

  89. MCNULTY MC, Stanford KA, Eller D, Sha BE, et al
    Concurrent Testing for COVID-19 and HIV Infection at 6 High-Volume Emergency Departments in a Priority Jurisdiction for Ending the HIV Epidemic in the United States.
    J Acquir Immune Defic Syndr. 2023;94:364-370.
    >> Share

  90. HECHTER RC, Zhou H, Leyden WA, Yuan Q, et al
    Fracture Risk and Association With TDF Use Among People With HIV in Large Integrated Health Systems.
    J Acquir Immune Defic Syndr. 2023;94:341-348.
    >> Share

  91. STARRETT GJ, Foster H, Sigel K, Liu Y, et al
    Brief Report: The Virome of Bladder Tumors Arising in People Living With HIV.
    J Acquir Immune Defic Syndr. 2023;94:337-340.
    >> Share

  92. MOMPER JD, Nikanjam M, Best BM, Mirochnick M, et al
    Brief Report: Dolutegravir Plasma Protein Binding and Unbound Concentrations During Pregnancy and Postpartum.
    J Acquir Immune Defic Syndr. 2023;94:332-336.
    >> Share

  93. MATHUR S, Mahapatra B, Mishra R, Heck CJ, et al
    Which Intervention Synergies Maximize AGYW's HIV Outcomes? A Classification and Regression Tree Analysis of Layered HIV Prevention Programming.
    J Acquir Immune Defic Syndr. 2023;94:317-324.
    >> Share

    November 2023
  94. ROSEN JG, Knox JR, Rucinski KB, Mcingana M, et al
    Polysubstance Use Profiles and HIV Viremia in a South African Cohort of Female Sex Workers: A Latent Class Analysis.
    J Acquir Immune Defic Syndr. 2023 Nov 30. doi: 10.1097/QAI.0000000000003356.
    >> Share

  95. FEELEMYER J, Bershteyn A, Scheidell JD, Brewer R, et al
    Impact of decarceration plus alcohol, substance use, and mental health screening on life expectancies of Black sexual minority men and Black transgender women (BSMM/BTW) living with HIV in the United States: A Simulation Study based on HPTN 061.
    J Acquir Immune Defic Syndr. 2023 Nov 28. doi: 10.1097/QAI.0000000000003354.
    >> Share

  96. BEARDEN DR, Mwanza-Kabaghe S, Bositis CM, Dallah I, et al
    Early Initiation of Antiretroviral Therapy is Protective Against Seizures in Children with HIV in Zambia: A Prospective Case-Control Study.
    J Acquir Immune Defic Syndr. 2023 Nov 28. doi: 10.1097/QAI.0000000000003357.
    >> Share

  97. BROOKS HL, Graves E, De Schacht C, Emilio A, et al
    "If it weren't for this, we'd be sick" - Perspectives from participants of a couple-based HIV treatment and support program during prenatal and postpartum periods in Zambezia Province, Mozambique.
    J Acquir Immune Defic Syndr. 2023 Nov 27. doi: 10.1097/QAI.0000000000003351.
    >> Share

  98. TRUONG HM, Heylen E, Kadede K, Amboka S, et al
    HIV Pre-Exposure Prophylaxis (PrEP) Awareness and Use Among Adolescents in Kenya.
    J Acquir Immune Defic Syndr. 2023 Nov 21. doi: 10.1097/QAI.0000000000003338.
    >> Share

  99. RIEBENSAHM C, Berzigotti A, Surial B, Haerry D, et al
    Decreased physical activity and prolonged sitting time are associated with liver steatosis in people with HIV.
    J Acquir Immune Defic Syndr. 2023 Nov 21. doi: 10.1097/QAI.0000000000003328.
    >> Share

  100. CRANE HM, Nance RM, Ruderman SA, Haidar L, et al
    Venous thromboembolism among people with HIV: Design, implementation, and findings of a centralized adjudication system in clinical care sites across the United States.
    J Acquir Immune Defic Syndr. 2023 Nov 21. doi: 10.1097/QAI.0000000000003339.
    >> Share

  101. VIGUERIE A, Song R, Bosh K, Lyles CM, et al
    Mortality among persons with HIV in the United States during the COVID-19 pandemic: a population-level analysis.
    J Acquir Immune Defic Syndr. 2023 Nov 20. doi: 10.1097/QAI.0000000000003347.
    >> Share

  102. ARNOLD EM, Kamal S, Rotheram-Borus MJ, Bridges SK, et al
    Factors Associated with Antiretroviral Adherence among Youth Living with HIV.
    J Acquir Immune Defic Syndr. 2023 Nov 17. doi: 10.1097/QAI.0000000000003345.
    >> Share

  103. DICKEY BL, Yanik EL, Thompson Z, Burkholder G, et al
    The association of HIV control and immunosuppression with risk of non-AIDS defining cancer risk among patients on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2023 Nov 16. doi: 10.1097/QAI.0000000000003350.
    >> Share

  104. MI T, Zhang J, Yang X, Chen S, et al
    Suicide ideation and attempt among people with HIV: A statewide population-level cohort analysis between 2005-2020.
    J Acquir Immune Defic Syndr. 2023 Nov 16. doi: 10.1097/QAI.0000000000003342.
    >> Share

  105. LIEGEON G, Brun A, Hamet G, Zeggagh J, et al
    Incidence and Management of Complex Kidney Situations Among On-demand and Daily HIV Pre-exposure Prophylaxis Users.
    J Acquir Immune Defic Syndr. 2023 Nov 16. doi: 10.1097/QAI.0000000000003346.
    >> Share

  106. JIANG W, Ronen K, Osborn L, Drake AL, et al
    HIV viral load patterns and risk factors among women in prevention of mother-to-child transmission (PMTCT) programs to inform differentiated service delivery (DSD).
    J Acquir Immune Defic Syndr. 2023 Nov 15. doi: 10.1097/QAI.0000000000003352.
    >> Share

  107. SHABA F, Balakasi K, Offorjebe OA, Nyirenda M, et al
    Facility HIV self-testing in outpatient departments: an assessment of characteristics and concerns of outpatients who opt-out of testing in Malawi.
    J Acquir Immune Defic Syndr. 2023 Nov 15. doi: 10.1097/QAI.0000000000003327.
    >> Share

  108. LANTING VR, Oosterhof P, Moha DA, van Heerde R, et al
    Switching to doravirine in cART experienced patients: An effective and highly tolerated option with substantial cost savings.
    J Acquir Immune Defic Syndr. 2023 Nov 10. doi: 10.1097/QAI.0000000000003337.
    >> Share

  109. SWANN SA, King EM, Prior JC, Berger C, et al
    Longitudinal assessment of bone mineral density in women living with and without HIV across reproductive phases.
    J Acquir Immune Defic Syndr. 2023 Nov 9. doi: 10.1097/QAI.0000000000003336.
    >> Share

  110. BOUSMAH MA, Protopopescu C, Mpoudi-Etame M, Omgba Bassega P, et al
    Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial).
    J Acquir Immune Defic Syndr. 2023;94:262-272.
    >> Share

  111. STENBERG E, Carlander C, Cao Y, Ottosson J, et al
    Metabolic and Bariatric Surgery for People Living With HIV-A Propensity-Matched Cohort Study.
    J Acquir Immune Defic Syndr. 2023;94:e5-e8.
    >> Share

  112. RODRIGUEZ VJ, Alcaide ML, Sued O, Aristegui I, et al
    Detection of Antiretrovirals in Transgender Women With HIV Is Not Altered by Hair Treatments.
    J Acquir Immune Defic Syndr. 2023;94:e3-e5.
    >> Share

  113. MCLAUGHLIN A, Lin N, Jiang W, Lodi S, et al
    Association of Alcohol Consumption With CD4 Recovery After Antiretroviral Therapy Initiation in St. Petersburg, Russia.
    J Acquir Immune Defic Syndr. 2023;94:244-252.
    >> Share

  114. MEYERS K, Quigee D, Zucker J, Carnevale C, et al
    The Index of Engagement in PrEP Care: Evaluation of Psychometric Properties and Predictive Potential.
    J Acquir Immune Defic Syndr. 2023;94:214-219.
    >> Share

  115. BILLICK MJ, Fisher KN, Myers S, Tan DHS, et al
    Brief Report: Outcomes of Individuals Using HIV Postexposure Prophylaxis-In-Pocket ("PIP") for Low-Frequency, High-Risk Exposures in Toronto, Canada.
    J Acquir Immune Defic Syndr. 2023;94:211-213.
    >> Share

  116. BANERJEE T, Frongillo EA, Turan JM, Sheira LA, et al
    Association of Higher Intake of Plant-Based Foods and Protein With Slower Kidney Function Decline in Women With HIV.
    J Acquir Immune Defic Syndr. 2023;94:203-210.
    >> Share

  117. RANSOME Y, Taggart T, Huang AS, Vermund SH, et al
    Increasing Spiritual Beliefs are Associated With Lower HIV Incidence Among Black Men Who Have Sex With Men: Results From HPTN 061 Longitudinal Study.
    J Acquir Immune Defic Syndr. 2023;94:196-202.
    >> Share

  118. LOGIE CH, Shannon K, Braschel M, Krusi A, et al
    Brief Report: Social Factors Associated With Trajectories of HIV-Related Stigma and Everyday Discrimination Among Women Living With HIV in Vancouver, Canada: Longitudinal Cohort Findings.
    J Acquir Immune Defic Syndr. 2023;94:190-195.
    >> Share

  119. FERNVIK E, Sierra Madero J, Espinosa N, Gulminetti R, et al
    Impact of Treatment Adherence on Efficacy of Dolutegravir + Lamivudine and Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Week 144 Analysis of the GEMINI-1 and GEMINI-2 Clinical Studies.
    J Acquir Immune Defic Syndr. 2023;94:e9-e12.
    >> Share

    October 2023
  120. GIOVENCO D, Pettifor A, Qayiya Y, Jones J, et al
    The acceptability, feasibility, and preliminary effectiveness of a courier HIV-treatment delivery and SMS support intervention for young people living with HIV in South Africa.
    J Acquir Immune Defic Syndr. 2023 Oct 18. doi: 10.1097/QAI.0000000000003332.
    >> Share

  121. MAHTAB S, Frigati LJ, Ntusi NAB, Nyathi M, et al
    The Determinants of Elevated Pathobiological Determination of Atherosclerosis in Youth risk score in Perinatally HIV Infected Adolescents in South Africa.
    J Acquir Immune Defic Syndr. 2023 Oct 18. doi: 10.1097/QAI.0000000000003304.
    >> Share

  122. BAIM-LANCE A, Addison D, Archer N, Gordon P, et al
    Integrating a Resilience Framework to Assess Implementation of a Novel HIV Care Re-engagement Model in NYC.
    J Acquir Immune Defic Syndr. 2023 Oct 18. doi: 10.1097/QAI.0000000000003285.
    >> Share

  123. VELEZ-DIAZ-PALLARES M, Silveira ED, Fradejas JF, Llorente BM, et al
    Potentially inappropriate prescribing in older people living with HIV: A scoping review.
    J Acquir Immune Defic Syndr. 2023 Oct 16. doi: 10.1097/QAI.0000000000003298.
    >> Share

  124. SHRESTHA RK, Hecht J, Chesson HW
    Analyzing the costs and impact of the TakeMeHome program, a public-private partnership to deliver HIV self-test kits in the United States.
    J Acquir Immune Defic Syndr. 2023 Oct 12. doi: 10.1097/QAI.0000000000003323.
    >> Share

  125. ISLAM MH, Shrestha RK, Hoch JS, Farnham PG, et al
    Estimating the cost-effectiveness of HIV self-testing in the United States using net benefit regression.
    J Acquir Immune Defic Syndr. 2023 Oct 12. doi: 10.1097/QAI.0000000000003325.
    >> Share

  126. HILL L, Kenney S, Patel N, Yin J, et al
    Predictors of post-switch viremia in people with HIV on injectable cabotegravir/rilpivirine.
    J Acquir Immune Defic Syndr. 2023 Oct 12. doi: 10.1097/QAI.0000000000003320.
    >> Share

  127. KATAREY D, Tan Y, Mourad A, Potts JR, et al
    Non-viral Liver Disease Burden in People Living with HIV and elevated transaminases: A Cross-sectional Study.
    J Acquir Immune Defic Syndr. 2023 Oct 12. doi: 10.1097/QAI.0000000000003322.
    >> Share

  128. MORRISON CA, Corbeil T, Kluisza L, Poku O, et al
    Identifying the Mental Health Effects of Cumulative Traumatic Exposure in HIV-Affected Youth: A Longitudinal Assessment.
    J Acquir Immune Defic Syndr. 2023 Oct 9. doi: 10.1097/QAI.0000000000003313.
    >> Share

  129. OMOZ-OARHE AE, Hughes MD, Bao Y, Short WR, et al
    Incidence and Predictors of Pregnancy in Women Enrolled in Large Multi-National HIV Treatment Trials of the AIDS Clinical Trials Group.
    J Acquir Immune Defic Syndr. 2023 Oct 9. doi: 10.1097/QAI.0000000000003299.
    >> Share

  130. RUDOLPH JE, Calkins K, Xu X, Wentz E, et al
    Comparing cancer incidence in an observational cohort of Medicaid beneficiaries with and without HIV, 2001-2015.
    J Acquir Immune Defic Syndr. 2023 Oct 9. doi: 10.1097/QAI.0000000000003318.
    >> Share

  131. CONVERY C, Diesel J, Brantley A, Miller J, et al
    Ryan White participation increased the prevalence of COVID-19 vaccination among PLWH in Michigan.
    J Acquir Immune Defic Syndr. 2023 Oct 5. doi: 10.1097/QAI.0000000000003315.
    >> Share

  132. ELLEN M, D FM, Inka A, Asa M, et al
    Perception and emotional experiences of infant feeding among women living with HIV in a high-income setting: A longitudinal mixed methods study.
    J Acquir Immune Defic Syndr. 2023 Oct 5. doi: 10.1097/QAI.0000000000003314.
    >> Share

  133. SLUIS-CREMER N, Traverso Aviles EE, Gonzalez OQ, Rios-Velazquez C, et al
    RING Program: The CFAR Diversity, Equity, and Inclusion Pathway Initiative.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  134. IRIE WC, Chitneni P, Glynn TR, Allen W, et al
    Pathways and Intersections: Multifaceted Approaches to Engage Individuals From Underrepresented and Marginalized Communities in HIV Research and Career Development.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  135. DELAMERCED J, Ramirez L, Kimberly JA, Vargas SI, et al
    Going to the Source: Discussions With Early and Mid-Career Faculty From Groups Underrepresented in Biomedical Research to Develop and Enhance CFAR Services.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  136. PALLIKKUTH S, Andre M, Owens F, Davis S, et al
    An Overview of Miami CDEIPI and a Showcase of Team Science and Cutting-Edge Research Driven by Students.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  137. PEREIRA FA, Newell AD, Rice AP
    Texas Developmental Center for AIDS Research CFAR Diversity, Equity, and Inclusion Pathway Initiative Program.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  138. DACUS JD, Wood CV, Ward D
    Partnering and Programming for a Black, Indigenous, and People of Color Sexual and Gender Minority Pathway to HIV Research.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  139. OKEKE NL, Ware KB, Campbell R, Taylor J, et al
    Evidence2Practice (E2P): Leveraging Implementation Science to Promote Careers in HIV Research Among Students From Historically Black Colleges and Universities.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  140. BALKUS JE, Conde M, Lewin A, Walters KL, et al
    Building Indigenuity, Generating HIV Science: An HIV/AIDS Research Training Program for Undergraduate and Graduate Indigenous Scholars (BIG HART).
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  141. FLORES JJ, Huang S, Sawyer S, Thomas M, et al
    Developing an Inclusive Generation of HIV Researchers Through Diversity and Community.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  142. KOETHE JR, Eeds A, Stewart LV, Haas DW, et al
    The Tennessee Center for AIDS Research HIV Research Training Program for Minority High School and Undergraduate Students: Development, Implementation, and Early Outcomes.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  143. PITPITAN EV, Campbell CK, Zuniga ML, Strathdee SA, et al
    Supporting and Uplifting New and Diverse Scientists in HIV Research (San Diego SUN): A Research Education and Training Program to Promote the Success of Black, Indigenous, and People of Color Predoctoral and Postdoctoral Fellows.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  144. KREIDER EF, Ortega-Burgos Y, Dumeng-Rodriguez J, Gesualdi J, et al
    Early Engagement in HIV Research: Evaluation of the Penn CFAR Scholars Program Aimed at Increasing Diversity of the HIV/AIDS Workforce.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  145. SAUCEDA JA, Watabe J, Sterling L, Fuchs J, et al
    Accelerating Research Careers in Science Through Early Mentored Research Experiences for Undergraduates and Masters' Students at the University of California, San Francisco Center for AIDS Research.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  146. MAGNUS M, Segarra L, Robinson B, Blankenship K, et al
    Impact of a Multi-Institutional Initiative to Engage Students and Early-Stage Scholars From Underrepresented Racial and Ethnic Minority Groups in HIV Research: The Centers for AIDS Research Diversity, Equity, and Inclusion Pathway Initiative.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  147. GREENBERG AE, Wutoh A, Bowleg L, Robinson B, et al
    Centers for AIDS Research (CFAR) Diversity, Equity, and Inclusion Pathway Initiative (CDEIPI): Developing Career Pathways for Early-Stage Scholars From Racial and Ethnic Groups Underrepresented in HIV Science and Medicine.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  148. HUGHES AJ, Nimbal V, Hsu L, Schwarcz S, et al
    Trends in Time Spent Viremic Among Persons Newly Diagnosed With HIV in San Francisco.
    J Acquir Immune Defic Syndr. 2023;94:107-115.
    >> Share

  149. MCCOLLUM CG, Carodine A, Chiedo A, Penney B, et al
    Social Support Assets and Needs of Underrepresented Students Participating in Health Sciences Pathways Programs in Birmingham, Alabama.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  150. ROBINSON SA, Menezes P, Zinck M, McCrimmon J, et al
    An Internship Approach to Strengthen the Pathway for Historically Underrepresented Groups in Health Sciences Research: The North Carolina Diversity and Inclusion Pathway Program.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  151. ANTOINE DG, Manogue S, Blue J, Irvin R, et al
    Addressing Stigma by Increasing Empathy Toward Vulnerable Populations in Preprofessional Trainees: Impacts of the Generation Tomorrow Summer Health Disparities Scholars Program.
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

  152. GREENBERG AE, Wutoh AK, Bowleg L, Magnus M, et al
    Supplemental Issue of the Journal of the Acquired Immune Deficiency Syndromes (JAIDS): The Centers for AIDS Research (CFAR) Diversity, Equity, and Inclusion Pathway Initiative (CDEIPI).
    J Acquir Immune Defic Syndr. 2023;94.
    >> Share

    September 2023
  153. LOMBARDO AR, Materi J, Caturegli G, Milovanovic M, et al
    Changing characteristics among in-hospital HIV deaths: An 11-year retrospective review of a regional hospital in South Africa.
    J Acquir Immune Defic Syndr. 2023 Sep 28. doi: 10.1097/QAI.0000000000003249.
    >> Share

  154. BEN FARHAT J, Hessamfar M, Farbos S, Desclaux A, et al
    Time to treatment initiation and HIV viral suppression in people diagnosed with HIV-1 during COVID-19 pandemic in ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study).
    J Acquir Immune Defic Syndr. 2023 Sep 28. doi: 10.1097/QAI.0000000000003310.
    >> Share

  155. GEIGER K, Patil A, Budhathoki C, Dooley KE, et al
    Successful MDR-TB Treatment Without HIV Viral Suppression: A Missed Opportunity.
    J Acquir Immune Defic Syndr. 2023 Sep 28. doi: 10.1097/QAI.0000000000003268.
    >> Share

  156. CHI BH, Saidi F, Graybill LA, Phanga T, et al
    A patient-centered, combination intervention to support adherence to HIV pre-exposure prophylaxis during pregnancy and breastfeeding: a randomized pilot study in Malawi.
    J Acquir Immune Defic Syndr. 2023 Sep 28. doi: 10.1097/QAI.0000000000003309.
    >> Share

  157. POLISENO M, Mazzitelli M, Narducci A, Ferrara SM, et al
    Doravirine plus Integrase Strand Transfer Inhibitors as a two-drugs treatment-switch strategy in PLWH: the real-life DORINI multicentric cohort study.
    J Acquir Immune Defic Syndr. 2023 Sep 27. doi: 10.1097/QAI.0000000000003248.
    >> Share

  158. BUNGE K, Balkus JE, Fairlie L, Mayo AJ, et al
    DELIVER: A Safety Study of a Dapivirine Vaginal Ring and Oral PrEP for the Prevention of HIV During Pregnancy.
    J Acquir Immune Defic Syndr. 2023 Sep 27. doi: 10.1097/QAI.0000000000003312.
    >> Share

  159. PARIKH UM, Penrose KJ, Heaps AL, Sethi R, et al
    HIV Drug Resistance Assessment among Women who Seroconverted during the MTN-025/HOPE Open-Label Extension Dapivirine Vaginal Ring Trial.
    J Acquir Immune Defic Syndr. 2023 Sep 20. doi: 10.1097/QAI.0000000000003308.
    >> Share

  160. N C, L H, Wdf V, S S, et al
    National impact of SARS-CoV-2 infection on HIV virological suppression in South Africa.
    J Acquir Immune Defic Syndr. 2023 Sep 19. doi: 10.1097/QAI.0000000000003307.
    >> Share

  161. TURPIN RE, Mandell CJ, Camp AD, Davidson Mhonde RR, et al
    Covid-19, Vaccine Hesitancy, and HIV pre-exposure prophylaxis among Black sexual minority men.
    J Acquir Immune Defic Syndr. 2023 Sep 15. doi: 10.1097/QAI.0000000000003305.
    >> Share

  162. TAHA TE, Bandala-Jacques A, Yende-Zuma N, Violari A, et al
    Breastfeeding Among Women living with HIV in the Era of Lifelong ART: An Observational Multi-Country Study in Eastern and Southern Africa.
    J Acquir Immune Defic Syndr. 2023 Sep 15. doi: 10.1097/QAI.0000000000003306.
    >> Share

    August 2023
  163. SHABANOVA V, Emuren L, Gan G, Antwi S, et al
    Pediatric HIV disclosure intervention improves immunologic outcome at 48 weeks: The Sankofa trial experience.
    J Acquir Immune Defic Syndr. 2023 Aug 28. doi: 10.1097/QAI.0000000000003292.
    >> Share

  164. BEER L, Williams D, Tie Y, McManus T, et al
    The Capacity of HIV Care Facilities to Implement Strategies Recommended by the Ending the HIV Epidemic-The Medical Monitoring Project Facility Survey.
    J Acquir Immune Defic Syndr. 2023 Aug 25. doi: 10.1097/QAI.0000000000003290.
    >> Share

  165. NAAR S, Kimball D, Cain D, Pooler M, et al
    Mechanisms of Successful Implementation of Tailored Motivational Interviewing in a Multi-site Study of Youth HIV Clinics in the United States.
    J Acquir Immune Defic Syndr. 2023 Aug 23. doi: 10.1097/QAI.0000000000003291.
    >> Share

  166. MCCORMICK LJ, Gutreuter S, Adeoye O, Alger SX, et al
    Cervical cancer screening positivity among women living with HIV in CDC-PEPFAR programs 2018-2022.
    J Acquir Immune Defic Syndr. 2023 Aug 23. doi: 10.1097/QAI.0000000000003286.
    >> Share

  167. DELONG SM, Xu Y, Genberg BL, Nyambura M, et al
    Population-based estimates and predictors of child and adolescent linkage to HIV care or death in western Kenya.
    J Acquir Immune Defic Syndr. 2023 Aug 22. doi: 10.1097/QAI.0000000000003288.
    >> Share

  168. ARYAL A, Leibowitz AA, Comulada WS, Rotheram-Borus MJ, et al
    PrEP use and HIV incidence among youth at-risk for HIV infection in Los Angeles and New Orleans: Findings from ATN 149.
    J Acquir Immune Defic Syndr. 2023 Aug 14. doi: 10.1097/QAI.0000000000003272.
    >> Share

  169. BOUSMAH MA, Protopopescu C, Mpoudi-Etame M, Bassega PO, et al
    Improvements in patient-reported outcomes following initiation of dolutegravir- or low-dose efavirenz-based first-line antiretroviral therapy: A four-year longitudinal analysis in Cameroon (NAMSAL ANRS 12313 trial).
    J Acquir Immune Defic Syndr. 2023 Aug 14. doi: 10.1097/QAI.0000000000003273.
    >> Share

  170. PUNJABI NM, Brown TT, Abreu AR, Aurora RN, et al
    Sleep-disordered Breathing and Prevalent Hypertension in Men With and Without HIV.
    J Acquir Immune Defic Syndr. 2023 Aug 14. doi: 10.1097/QAI.0000000000003276.
    >> Share

  171. KALICHMAN SC, Kalichman MO, Eaton LA
    Phone-Delivered Intervention to Improve HIV Care for Young People Living with HIV: Trial to Inform Implementation and Utility.
    J Acquir Immune Defic Syndr. 2023 Aug 14. doi: 10.1097/QAI.0000000000003279.
    >> Share

  172. GRINSZTEJN E, Cardoso SW, Velasque L, Hoagland B, et al
    Impact of latent M. tuberculosis infection treatment on time to CD4/CD8 recovery in acute, recent and chronic HIV infection.
    J Acquir Immune Defic Syndr. 2023 Aug 9. doi: 10.1097/QAI.0000000000003284.
    >> Share

    June 2023
  173. SHENGIR M, Fillebeen C, Wagner J, Ramanakumar AV, et al
    Increased serum fibroblast growth factor 23 predicts mortality in people with HIV/HCV coinfection.
    J Acquir Immune Defic Syndr. 2023 Jun 27. doi: 10.1097/QAI.0000000000003245.
    >> Share

  174. EPEDLEGUI M, Chang D, Lee J, Magpantay LI, et al
    Predictive value of serum biomarkers for response of limited-stage AIDS-associated Kaposi sarcoma to antiretroviral therapy with or without concomitant chemotherapy in resource-limited settings.
    J Acquir Immune Defic Syndr. 2023 Jun 27. doi: 10.1097/QAI.0000000000003236.
    >> Share

  175. RUDERMAN SA, Odden MC, Webel AR, Fitzpatrick AL, et al
    Tobacco Smoking and Pack-years are Associated with Frailty Among People with HIV.
    J Acquir Immune Defic Syndr. 2023 Jun 26. doi: 10.1097/QAI.0000000000003242.
    >> Share

  176. MALAMA K, Logie CH, Sokolovic N, Skeritt L, et al
    Pathways from HIV-related stigma, racial discrimination and gender discrimination to HIV treatment outcomes among women living with HIV in Canada: longitudinal cohort findings.
    J Acquir Immune Defic Syndr. 2023 Jun 26. doi: 10.1097/QAI.0000000000003241.
    >> Share

  177. CASTEL AD, Barth S, Wilbourn BC, Horberg M, et al
    Trends in COVID-19 Vaccine Hesitancy and Uptake among Persons Living with HIV in Washington, DC.
    J Acquir Immune Defic Syndr. 2023 Jun 26. doi: 10.1097/QAI.0000000000003243.
    >> Share

  178. ERLANDSON KM, Umbleja T, Lu MT, Taron J, et al
    Associations of Muscle Density and Area with Coronary Artery Plaque and Physical Function.
    J Acquir Immune Defic Syndr. 2023 Jun 26. doi: 10.1097/QAI.0000000000003244.
    >> Share

  179. MASTERS MC, Rivera J, Calamari M, Wright K, et al
    Telemedicine and HIV care quality measures during the COVID-19 pandemic.
    J Acquir Immune Defic Syndr. 2023 Jun 26. doi: 10.1097/QAI.0000000000003238.
    >> Share

  180. MAIERHOFER CN, Powers KA, Matoga MM, Chen JS, et al
    Characterizing network-based HIV testing interventions to guide HIV testing and contact tracing at STI clinics in Lilongwe, Malawi.
    J Acquir Immune Defic Syndr. 2023 Jun 21. doi: 10.1097/QAI.0000000000003240.
    >> Share

  181. VASISHTA S, Dieterich D, Mullen M, Aberg J, et al
    Hepatitis B infection or reactivation after switch to two-drug antiretroviral therapy: A case series, literature review, and management discussion.
    J Acquir Immune Defic Syndr. 2023 Jun 21. doi: 10.1097/QAI.0000000000003239.
    >> Share

  182. MERCEDES RA, Kasbaum MA, George PE, Tumweheire EG, et al
    Nutritional Recovery of Children with HIV and Severe Acute Malnutrition Attending an Outpatient Therapeutic Care Program.
    J Acquir Immune Defic Syndr. 2023 Jun 9. doi: 10.1097/QAI.0000000000003222.
    >> Share

  183. MUYINDA H, Jongbloed K, Zamar DS, Malamba SS, et al
    Cango Lyec (Healing the Elephant): HIV prevalence and vulnerabilities among adolescent girls and young women in post-conflict Northern Uganda.
    J Acquir Immune Defic Syndr. 2023 Jun 5. doi: 10.1097/QAI.0000000000003234.
    >> Share

  184. REIS AO, Rocco Suassuna JH, Cunha CB, Portela EN, et al
    Evaluation of glomerular filtration rate trends in people living with HIV corrected by the baseline glomerular filtration rate.
    J Acquir Immune Defic Syndr. 2023 Jun 1. doi: 10.1097/QAI.0000000000003232.
    >> Share

  185. ELLSWORTH G, Shen R, Marcellin KA, Majumdar R, et al
    High specificity of HPV cell free DNA tests in persons with HIV for the detection of HPV-related cancer.
    J Acquir Immune Defic Syndr. 2023 Jun 1. doi: 10.1097/QAI.0000000000003231.
    >> Share

  186. D'ANGELO AB, Mirzayi C, Carneiro PB, Grov C, et al
    Changes in Cost and Insurance Challenges to Cover PrEP Between 2019 and 2021.
    J Acquir Immune Defic Syndr. 2023;93:116-125.
    >> Share

    May 2023
  187. RIAL-CRESTELO D, Pinto-Martinez A, Navarro-Soler R, Pulido F, et al
    Deep sequencing on proviral DNA: more questions than answers.
    J Acquir Immune Defic Syndr. 2023 May 29. doi: 10.1097/QAI.0000000000003230.
    >> Share

  188. PYRA M, Kline J, Taylor O, Rusie L, et al
    Changes in HIV Prevention & Sexual Experiences During the COVID-19 Pandemic: A mixed-methods study.
    J Acquir Immune Defic Syndr. 2023 May 26. doi: 10.1097/QAI.0000000000003229.
    >> Share

  189. SHAW SY, Reed N, Wanjiru TD, Muriuki F, et al
    Geographical associations of HIV prevalence in female sex workers from Nairobi, Kenya (2014-2017).
    J Acquir Immune Defic Syndr. 2023 May 24. doi: 10.1097/QAI.0000000000003219.
    >> Share

  190. THOMAS MD, Vittinghoff E, Koester KA, Dahiya P, et al
    Examining the Impact of State-Level Factors on HIV Testing for Medicaid Enrollees with Schizophrenia.
    J Acquir Immune Defic Syndr. 2023 May 24. doi: 10.1097/QAI.0000000000003225.
    >> Share

  191. SISE ME, Katz-Agranov N, Strohbehn IA, Harden D, et al
    Use and Side Effects of Sodium Glucose Transporter 2 Inhibitors among U.S. People with HIV with Clinical Indications.
    J Acquir Immune Defic Syndr. 2023 May 24. doi: 10.1097/QAI.0000000000003227.
    >> Share

  192. PURYEAR SB, Ayieko J, Hahn JA, Mucunguzi A, et al
    Universal HIV Testing and Treatment with Patient-Centered Care Improves ART Uptake and Viral Suppression among Adults Reporting Hazardous Alcohol Use in Uganda and Kenya.
    J Acquir Immune Defic Syndr. 2023 May 22. doi: 10.1097/QAI.0000000000003226.
    >> Share

  193. PATTERSON W, Rosenthal M, Rajulu DT
    Trends in HIV Mortality in the Context of the COVID-19 Pandemic.
    J Acquir Immune Defic Syndr. 2023 May 22. doi: 10.1097/QAI.0000000000003228.
    >> Share

  194. RACCAGNI AR, Ceccarelli D, Trentacapilli B, Galli L, et al
    Viral Hepatitis and Human Papillomavirus Vaccination during HIV Pre-exposure Prophylaxis: Factors Associated with Missed Vaccination.
    J Acquir Immune Defic Syndr. 2023 May 18. doi: 10.1097/QAI.0000000000003216.
    >> Share

  195. VHEMBO T, Baltrusaitis K, Tierney C, Owor M, et al
    Bone and renal health in infants with or without breastmilk exposure to tenofovir-based maternal antiretroviral treatment in the PROMISE randomized trial.
    J Acquir Immune Defic Syndr. 2023 May 15. doi: 10.1097/QAI.0000000000003218.
    >> Share

  196. ABIOYE AI, Hughes MD, Sudfeld CR, Noor RA, et al
    Dietary iron intake and HIV-related outcomes among adults initiating antiretroviral therapy in Tanzania.
    J Acquir Immune Defic Syndr. 2023 May 15. doi: 10.1097/QAI.0000000000003221.
    >> Share

  197. CHANG LW, Pollard R, Mbabali I, Anok A, et al
    A Mixed Methods, Implementation Science Evaluation of a Community Health Worker Strategy for HIV Service Engagement in Uganda.
    J Acquir Immune Defic Syndr. 2023 May 15. doi: 10.1097/QAI.0000000000003220.
    >> Share

  198. EATON LA, Layland EA, Driver R, Kalichman SC, et al
    Novel Latent Profile Analysis of a Test of Concept, Stigma Intervention to Increase PrEP Uptake Among Black Sexual Minority Men.
    J Acquir Immune Defic Syndr. 2023 May 15. doi: 10.1097/QAI.0000000000003223.
    >> Share

  199. BROADY TR, Chan C, MacGibbon J, Mao L, et al
    Changing characteristics of HIV-positive gay and bisexual men's relationships in the era of biomedical prevention.
    J Acquir Immune Defic Syndr. 2023 May 15. doi: 10.1097/QAI.0000000000003224.
    >> Share

  200. LEUNG SOO C, Bhatnagar S, Bartlett SJ, Esmail A, et al
    Development and Evaluation of a Digital HIV Risk Assessment Tool incorporated within an App-Based Self-Testing Program.
    J Acquir Immune Defic Syndr. 2023 May 10. doi: 10.1097/QAI.0000000000003210.
    >> Share

  201. KNETTEL BA, Amiri I, Minja L, Martinez AJ, et al
    Task-shifting 'gold standard' clinical assessment and safety planning for suicide risk among people living with HIV: A feasibility and fidelity evaluation in Tanzania.
    J Acquir Immune Defic Syndr. 2023 May 8. doi: 10.1097/QAI.0000000000003217.
    >> Share

  202. TUDDENHAM S, Shafiq M, Mathad JS, Alexander M, et al
    Association of Pregnancy and HIV Status with Molecular-Bacterial Vaginosis in Indian Women.
    J Acquir Immune Defic Syndr. 2023 May 8. doi: 10.1097/QAI.0000000000003215.
    >> Share

  203. RAIFORD JL, Yuan X, Carree T, Beer L, et al
    Understanding Disparities in Antiretroviral Therapy Adherence and Sustained Viral Suppression among Black, Hispanic/Latina, and White Women in the United States - Medical Monitoring Project, United States, 2015-2019.
    J Acquir Immune Defic Syndr. 2023 May 1. doi: 10.1097/QAI.0000000000003214.
    >> Share

    April 2023
  204. ABUOGI L, Smith C, Kinzie K, Barr E, et al
    Development and implementation of an interdisciplinary model for the management of breastfeeding in women with HIV in the United States: experience from the Children's Hospital Colorado Immunodeficiency Program.
    J Acquir Immune Defic Syndr. 2023 Apr 27. doi: 10.1097/QAI.0000000000003213.
    >> Share

  205. OMOLLO V, Asewe M, Mogere P, Maina G, et al
    The fidelity of a pharmacy-based oral HIV pre-exposure prophylaxis delivery model in Kenya.
    J Acquir Immune Defic Syndr. 2023 Apr 19. doi: 10.1097/QAI.0000000000003208.
    >> Share

  206. GANDHI AR, Hyle EP, Scott JA, Lee JS, et al
    The clinical impact and cost-effectiveness of clinic-based cognitive behavioral therapy for people with HIV, depression, and virologic failure in South Africa.
    J Acquir Immune Defic Syndr. 2023 Apr 19. doi: 10.1097/QAI.0000000000003205.
    >> Share

  207. LEW C, Fairley CK, Tran J, Phillips TR, et al
    High risk sexual activities and condom use patterns during group sex among men who have sex with men in Melbourne, Australia.
    J Acquir Immune Defic Syndr. 2023 Apr 19. doi: 10.1097/QAI.0000000000003211.
    >> Share

  208. DORWARD J, Sookrajh Y, Lessells R, Bulo E, et al
    Point-of-care viral load testing to manage HIV viraemia during the rollout of dolutegravir-based ART in South Africa: a randomised feasibility study (POwER).
    J Acquir Immune Defic Syndr. 2023 Apr 19. doi: 10.1097/QAI.0000000000003212.
    >> Share

  209. LESIAPETO M, Shults J, Mmunyane M, Matshaba M, et al
    Stunted Growth is Associated with Dyslipidemia in Young Adults with Perinatal HIV Infection.
    J Acquir Immune Defic Syndr. 2023 Apr 17. doi: 10.1097/QAI.0000000000003209.
    >> Share

  210. GRAHAM SM, Nance RM, Chen J, Wurfel MM, et al
    Plasma interleukin-6 (IL-6), angiopoietin-2, and C-reactive protein levels predict subsequent type 1 myocardial infarction in persons with treated HIV infection.
    J Acquir Immune Defic Syndr. 2023 Apr 5. doi: 10.1097/QAI.0000000000003207.
    >> Share

  211. KING EM, Carter A, Loutfy M, Webster K, et al
    Sexual satisfaction of midlife women living with HIV in Canada: A prospective cohort analysis.
    J Acquir Immune Defic Syndr. 2023 Apr 4. doi: 10.1097/QAI.0000000000003204.
    >> Share

  212. CHAMA J, Adebiyi R, Volpi C, Ononaku U, et al
    Prevalence and Predictors of Concern about Anal Cancer among Sexual and Gender Minorites Living with HIV in Abuja, Nigeria.
    J Acquir Immune Defic Syndr. 2023 Apr 4. doi: 10.1097/QAI.0000000000003206.
    >> Share

  213. GOLDEN MR, Mamudo A, Vio F, Branigan E, et al
    Assisted Partner Notification Services are Safe and Effective as they are Brought to Scale in Mozambique.
    J Acquir Immune Defic Syndr. 2023 Apr 4. doi: 10.1097/QAI.0000000000003203.
    >> Share

  214. PATTEN G, Sipambo N, Technau KG, Euvrard J, et al
    Ongoing High Prevalence of Severe Immune Suppression Among Children in South Africa.
    J Acquir Immune Defic Syndr. 2023;92:273-280.
    >> Share

    March 2023
  215. YANG B, Sloot R, Floyd S, Awoniyi D, et al
    How do we reach men? Offering HIV testing in evenings and weekends in the HPTN 071 (PopART) community-based trial in South Africa.
    J Acquir Immune Defic Syndr. 2023 Mar 31. doi: 10.1097/QAI.0000000000003197.
    >> Share

  216. BOTTANELLI M, Ceccarelli D, Lolatto R, Galli L, et al
    RISK OF CARDIOVASCULAR DISEASES OR MORTALITY IN PEOPLE WITH HIGHER VALUES OF HIV-1 DNA.
    J Acquir Immune Defic Syndr. 2023 Mar 29. doi: 10.1097/QAI.0000000000003192.
    >> Share

  217. OKEGBE T, Williams J, Plourde KF, Oliver K, et al
    Impact of COVID-19 on HIV Adolescent Programming in 16 Countries with USAID-supported PEPFAR Programs.
    J Acquir Immune Defic Syndr. 2023 Mar 29. doi: 10.1097/QAI.0000000000003201.
    >> Share

  218. STAMP BF, Powers KA, Horvath KJ, Soberano ZR, et al
    Prediction of Sex and the Potential Use of On-Demand PrEP Among Young Men Who Have Sex With Men in the U.S.
    J Acquir Immune Defic Syndr. 2023 Mar 29. doi: 10.1097/QAI.0000000000003202.
    >> Share

  219. GARIMELLA PS, Scherzer R, Kestenbaum BR, Hoofnagle AN, et al
    tubular secretory solute clearance and hiv infection.
    J Acquir Immune Defic Syndr. 2023 Mar 29. doi: 10.1097/QAI.0000000000003200.
    >> Share

  220. CAMPBELL CK, Dube K, Sauceda JA, Sevelius JM, et al
    Cash Transfer Apps are a Feasible, Acceptable, and More Equitable Method for Compensating Participants in HIV Research.
    J Acquir Immune Defic Syndr. 2023 Mar 27. doi: 10.1097/QAI.0000000000003199.
    >> Share

  221. ROSEN JG, Mbizvo MT, Phiri L, Chibuye M, et al
    Depression-mediating pathways from household adversity to antiretroviral therapy non-adherence among children and adolescents living with HIV in Zambia: a structural equation modeling approach.
    J Acquir Immune Defic Syndr. 2023 Mar 27. doi: 10.1097/QAI.0000000000003193.
    >> Share

  222. JENNINGS L, Ferraris CM, Castillo-Mancilla JR, Robbins RN, et al
    Comparing predictive ability of two objective adherence measures in a community-based cohort on antiretroviral therapy in South Africa: tenofovir diphosphate concentrations and electronic adherence monitors.
    J Acquir Immune Defic Syndr. 2023 Mar 27. doi: 10.1097/QAI.0000000000003198.
    >> Share

  223. KAVISHE BB, PrayGod G, Brage S, Kitilya BW, et al
    Changes in nocturnal heart rate variability in people living with HIV during the first year of antiretroviral therapy compared to HIV-uninfected community controls.
    J Acquir Immune Defic Syndr. 2023 Mar 23. doi: 10.1097/QAI.0000000000003191.
    >> Share

  224. THORMAN J, Bjorkman P, Sasinovich S, Tesfaye F, et al
    Performance of Galectin-9 for identification of HIV viremia in adults receiving antiretroviral therapy in a resource-limited setting.
    J Acquir Immune Defic Syndr. 2023 Mar 23. doi: 10.1097/QAI.0000000000003196.
    >> Share

  225. GAITAN NC, D'Antoni ML, Acosta RK, Gianella S, et al
    Comparative analysis of pre-existing HIV drug resistance mutations in proviral DNA via Next-Generation Sequencing and routine HIV RNA genotyping.
    J Acquir Immune Defic Syndr. 2023 Mar 23. doi: 10.1097/QAI.0000000000003195.
    >> Share

  226. BUNDGARD J, Reimer Jensen AM, Suarez-Zdunek MA, Hogh J, et al
    Peripheral artery disease and markers of endothelial dysfunction and platelet activation in people with HIV.
    J Acquir Immune Defic Syndr. 2023 Mar 23. doi: 10.1097/QAI.0000000000003194.
    >> Share

  227. FILIPPIDIS P, Damas J, Viala B, Assal F, et al
    Cerebrospinal fluid HIV-1 escape in patients with neurocognitive symptoms: pooled data from a neuro-HIV platform and the NAMACO study.
    J Acquir Immune Defic Syndr. 2023 Mar 15. doi: 10.1097/QAI.0000000000003189.
    >> Share

  228. LEE JJ, Barry MP, Kerani RP, Sanchez TH, et al
    The Pre-Exposure Prophylaxis (PrEP) Care Continuum among English-Speaking Latino Sexual Minority Men in the United States (2014-2020).
    J Acquir Immune Defic Syndr. 2023 Mar 15. doi: 10.1097/QAI.0000000000003187.
    >> Share

  229. MUGO C, Zubayr B, Ezeokafor N, Oyawola B, et al
    Effect of Dolutegravir and multi-month dispensing on viral suppression among children with HIV.
    J Acquir Immune Defic Syndr. 2023 Mar 15. doi: 10.1097/QAI.0000000000003190.
    >> Share

  230. SAUCEDA JA, Dube K, Harris O, Campbell CK, et al
    The influence of the COVID-19 pandemic on the physical, social, and mental health of Black and Latinx young people with HIV in the United States.
    J Acquir Immune Defic Syndr. 2023 Mar 13. doi: 10.1097/QAI.0000000000003188.
    >> Share

  231. SSEMPIJJA V, Ssekubugu R, Kigozi G, Nakigozi G, et al
    DYNAMICS OF PRE-EXPOSURE (PrEP) ELIGIBILITY DUE TO WAXING AND WANING OF HIV RISK IN RAKAI, UGANDA.
    J Acquir Immune Defic Syndr. 2023 Mar 6. doi: 10.1097/QAI.0000000000003182.
    >> Share

  232. HAMILL MM, Hu F, Adebajo S, Kokogho A, et al
    Food and water insecurity in sexual and gender minority groups living with HIV in Lagos, Nigeria.
    J Acquir Immune Defic Syndr. 2023 Mar 6. doi: 10.1097/QAI.0000000000003183.
    >> Share

  233. SATANON S, Kiertiburanakul S, Boonnak K, Bruminhent J, et al
    A Prospective Immunogenicity Study of a Quadrivalent Inactivated Influenza Vaccine among persons with HIV with Different Levels of CD4 Cell Count.
    J Acquir Immune Defic Syndr. 2023 Mar 6. doi: 10.1097/QAI.0000000000003186.
    >> Share

  234. POTEAT TC, Wirtz AL, Adams D, Linton SL, et al
    Interruptions in HIV Prevention and Treatment Due to the COVID-19 Pandemic: A Cross-sectional Study of Transgender and Gender Nonbinary Adults in the U.S.
    J Acquir Immune Defic Syndr. 2023 Mar 6. doi: 10.1097/QAI.0000000000003185.
    >> Share

  235. YU X, Kuo YF, Raji MA, Berenson AB, et al
    Dementias among older males and females in the U.S. Medicare system with and without HIV.
    J Acquir Immune Defic Syndr. 2023 Mar 6. doi: 10.1097/QAI.0000000000003184.
    >> Share


  236. Modeling the Risk of HIV Transfusion Transmission: Erratum.
    J Acquir Immune Defic Syndr. 2023;92:271.
    >> Share

  237. QIAN Y, Wang L, Xing Y, Yin L, et al
    Tenofovir concentration is not enough in intraocular tissues of patients with HIV-infection.
    J Acquir Immune Defic Syndr. 2023 Mar 1. doi: 10.1097/QAI.0000000000003171.
    >> Share

  238. OKEGBE T, Amzel A, Gunnala R, Abuelgasim K, et al
    A Landscape Analysis of Prevention of Vertical Transmission Program Data and Interventions from Fiscal Years 2019 to 2021.
    J Acquir Immune Defic Syndr. 2023 Mar 1. doi: 10.1097/QAI.0000000000003181.
    >> Share

  239. WEIMANN L, Schafer G, Matthews H, Maria F, et al
    Prospective single center cohort study on HIV pre-exposure prophylaxis reveals transient but relevant elevations in transaminase levels in some participants albeit otherwise high tolerability.
    J Acquir Immune Defic Syndr. 2023 Mar 1. doi: 10.1097/QAI.0000000000003170.
    >> Share

    February 2023
  240. O'SHEA J, Fanfair RN, Williams T, Khalil G, et al
    The Cooperative Re-Engagement Controlled Trial (CoRECT): Durable Viral Suppression Assessment.
    J Acquir Immune Defic Syndr. 2023 Feb 21. doi: 10.1097/QAI.0000000000003178.
    >> Share

  241. BOLLINGER JM, Geller G, May E, Brewer J, et al
    Challenges in Obtaining the Informed Perspectives of Stakeholders regarding HIV Molecular Epidemiology.
    J Acquir Immune Defic Syndr. 2023 Feb 21. doi: 10.1097/QAI.0000000000003179.
    >> Share

  242. ROSENTHAL EM, Patterson W, Chicoine J, Dorabawila V, et al
    COVID-19 vaccination and hospitalization among persons living with diagnosed HIV in New York State.
    J Acquir Immune Defic Syndr. 2023 Feb 21. doi: 10.1097/QAI.0000000000003177.
    >> Share

  243. ELBUR AI, Ghebremichael M, Konkle-Parker D, Jones DL, et al
    Trajectories of Antiretroviral Therapy Adherence and Virologic Failure in Women with HIV in the United States.
    J Acquir Immune Defic Syndr. 2023 Feb 20. doi: 10.1097/QAI.0000000000003174.
    >> Share

  244. WANG M, Violette LR, Dorward J, Ngobese H, et al
    Delivery of Community-based Antiretroviral Therapy to MaintainViral Suppression and Retention in Care in South Africa.
    J Acquir Immune Defic Syndr. 2023 Feb 15. doi: 10.1097/QAI.0000000000003176.
    >> Share

  245. VAN PRAET JT, Serrien B, Ausselet N, Darcis G, et al
    Dynamics of weight change after initiation of contemporaneous antiretroviral therapy in treatment-naive HIV-1 patients: results from the Belgian HIV Cohort 2015-2021.
    J Acquir Immune Defic Syndr. 2023 Feb 14. doi: 10.1097/QAI.0000000000003175.
    >> Share

  246. HICKEY MD, Wafula E, Ogachi SM, Ojwando H, et al
    Weight change following switch to dolutegravir for HIV treatment in rural Kenya during country roll-out.
    J Acquir Immune Defic Syndr. 2023 Feb 14. doi: 10.1097/QAI.0000000000003173.
    >> Share

  247. DI PR, Van Leeuwen MT, Amin J, Vajdic CM, et al
    Second primary cancers in people with HIV/AIDS: a national data linkage study of incidence and risk factors.
    J Acquir Immune Defic Syndr. 2023 Feb 13. doi: 10.1097/QAI.0000000000003172.
    >> Share

  248. HAN WM, Avihingsanon A, Rajasuriar R, Tanuma J, et al
    CD4/CD8 Ratio Recovery Among People Living With HIV Starting With First-Line Integrase Strand Transfer Inhibitors: A Prospective Regional Cohort Analysis.
    J Acquir Immune Defic Syndr. 2023;92:180-188.
    >> Share

  249. HODGE D, Hodel EM, Hughes E, Hazenberg P, et al
    Prevalence of Potentially Clinically Significant Drug-Drug Interactions With Antiretrovirals Against HIV Over Three Decades: A Systematic Review of the Literature.
    J Acquir Immune Defic Syndr. 2023;92:97-105.
    >> Share

  250. JACOBS TG, Mumbiro V, Chitsamatanga M, Namuziya N, et al
    Suboptimal lopinavir exposure in infants on rifampicin treatment receiving double-dosed or semi-superboosted lopinavir/ritonavir: time for a change.
    J Acquir Immune Defic Syndr. 2023 Feb 1. doi: 10.1097/QAI.0000000000003168.
    >> Share

    January 2023
  251. BLACK DA, LaCourse SM, Njuguna IN, Beima-Sofie KM, et al
    Tuberculosis preventative therapy initiation and completion among adolescents and young adults with HIV in Kenya.
    J Acquir Immune Defic Syndr. 2023 Jan 31. doi: 10.1097/QAI.0000000000003131.
    >> Share

  252. YEE WH, Li WP, Bador MK, Li CM, et al
    Poor HIV-Related Outcomes In Older Adults Newly Diagnosed with HIV: A Four-Year Retrospective Analysis from A Single Site in Asia.
    J Acquir Immune Defic Syndr. 2023 Jan 30. doi: 10.1097/QAI.0000000000003169.
    >> Share

  253. HRAPCAK S, Hast M, Okegbe T, Gross J, et al
    The status of adolescent testing and treatment in PEPFAR-supported programs, October 2017-September 2020.
    J Acquir Immune Defic Syndr. 2023 Jan 30. doi: 10.1097/QAI.0000000000003166.
    >> Share

  254. ENGLISH D, Smith JC, Scott-Walker L, Lopez FG, et al
    Feasibility, Acceptability, and Preliminary HIV Care and Psychological Health Effects of iTHRIVE 365 for Black Same Gender Loving Men.
    J Acquir Immune Defic Syndr. 2023 Jan 27. doi: 10.1097/QAI.0000000000003167.
    >> Share

  255. KEENE CM, Cassidy T, Zhao Y, Griesel R, et al
    Recycling tenofovir in second-line antiretroviral treatment with dolutegravir: outcomes and viral load trajectories to 72 weeks.
    J Acquir Immune Defic Syndr. 2023 Jan 25. doi: 10.1097/QAI.0000000000003157.
    >> Share

  256. BENKI-NUGENT S, Tamasha N, Mueni A, Laboso T, et al
    Early antiretroviral therapy reduces severity but does not eliminate neurodevelopmental compromise in children with HIV.
    J Acquir Immune Defic Syndr. 2023 Jan 23. doi: 10.1097/QAI.0000000000003165.
    >> Share

  257. BAGCHI S, Kwapong YA, Schar M, Bonanno G, et al
    The Relationship between Impaired Coronary Endothelial Function and Systemic Markers of Inflammation in People Living with HIV.
    J Acquir Immune Defic Syndr. 2023 Jan 11. doi: 10.1097/QAI.0000000000003162.
    >> Share

  258. CUMMINGS MJ, Bakamutumaho B, Jain K, Price A, et al
    Detection of urine lipoarabinomannan is associated with pro-inflammatory innate immune activation, impaired host defense, and organ dysfunction in adults with severe HIV-associated tuberculosis in Uganda.
    J Acquir Immune Defic Syndr. 2023 Jan 11. doi: 10.1097/QAI.0000000000003159.
    >> Share

  259. STONER MCD, Browne EN, Kabudula C, Rosenberg M, et al
    The effects of participation in an intensive HIV prevention trial on long term socio-demographic outcomes among young women in rural South Africa.
    J Acquir Immune Defic Syndr. 2023 Jan 11. doi: 10.1097/QAI.0000000000003161.
    >> Share

  260. CHAPIN-BARDALES J, Haaland R, Martin A, Holder A, et al
    HIV pre-exposure prophylaxis persistence and adherence among men who have sex with men in 4 U.S. cities.
    J Acquir Immune Defic Syndr. 2023 Jan 9. doi: 10.1097/QAI.0000000000003160.
    >> Share

  261. LIANG C, Suen SC, Nguyen A, Moucheraud C, et al
    The Impact of COVID-19 Response on the HIV Epidemic in Men Who Have Sex with Men in San Francisco County: The Importance of Rapid Return to Normalcy.
    J Acquir Immune Defic Syndr. 2023 Jan 6. doi: 10.1097/QAI.0000000000003156.
    >> Share

  262. GANESAN K, Mwesigwa R, Dear N, Esber AL, et al
    EPIDEMIOLOGY OF TUBERCULOSIS AMONG PEOPLE LIVING WITH HIV IN THE AFRICAN COHORT STUDY FROM 2013-2021.
    J Acquir Immune Defic Syndr. 2023 Jan 3. doi: 10.1097/QAI.0000000000003152.
    >> Share

  263. HACHFELD A, Atkinson A, Stute P, Calmy A, et al
    Does menopause transition influence viral suppression and adherence in Women living with HIV?
    J Acquir Immune Defic Syndr. 2023 Jan 2. doi: 10.1097/QAI.0000000000003158.
    >> Share

  264. TELES MS, Lushniak S, Po-Yu Chiang T, Bailey JR, et al
    Immunogenicity and Reactogenicity Following 2- and 3-Dose SARS-CoV-2 Vaccination in Persons With HIV.
    J Acquir Immune Defic Syndr. 2023;92:e1.
    >> Share

    December 2022
  265. OKWUEGBUNA OK, Kaur H, Ludicello J, Bush WS, et al
    Anemia and Erythrocyte Indices are Associated with Neurocognitive Performance Across Multiple Ability Domains in Adults with HIV.
    J Acquir Immune Defic Syndr. 2022 Dec 28. doi: 10.1097/QAI.0000000000003155.
    >> Share

  266. MILLER MJ, Eberhart LG, Jefferson CR, Horberg MA, et al
    Beyond Antiretroviral Treatment: Patterns and Factors Associated with Composite Medication Adherence Before and During the COVID-19 Pandemic in Patients with HIV with Multiple Chronic Conditions.
    J Acquir Immune Defic Syndr. 2022 Dec 26. doi: 10.1097/QAI.0000000000003154.
    >> Share

  267. L'YAVANC T, Gosset D, Platey M, Jedrzejewski T, et al
    Is there a reduction in chemsex practice in men who have sex with men during Covid-19 lockdown? Results of the CheRRLock study.
    J Acquir Immune Defic Syndr. 2022 Dec 19. doi: 10.1097/QAI.0000000000003153.
    >> Share

  268. ASKARI A, Nashier C, Ghelani R, Zhang AV, et al
    Switching to high genetic-barrier integrase inhibitors reduces drug-drug interactions in people living with HIV.
    J Acquir Immune Defic Syndr. 2022 Dec 19. doi: 10.1097/QAI.0000000000003151.
    >> Share


  269. Efficacy and Safety of a Simplified Lamivudine Plus Dolutegravir Dual Therapy in HIV-1-Infected Patients: A Multicenter Cohort Study in China: Erratum.
    J Acquir Immune Defic Syndr. 2022;91:516.
    >> Share

  270. GOVENDER T, Jham MA, Zhang JC, Pillay S, et al
    Decentralized, integrated treatment of RR/MDR-TB and HIV using a bedaquiline-based, short regimen is effective and associated with improved HIV disease control.
    J Acquir Immune Defic Syndr. 2022 Dec 15. doi: 10.1097/QAI.0000000000003150.
    >> Share

  271. IRVINE MK, Levin B, Abdelqader F, Carmona J, et al
    Evaluation of the revised versus original Ryan White Part A HIV Care Coordination Program in a cluster-randomized, stepped-wedge trial.
    J Acquir Immune Defic Syndr. 2022 Dec 15. doi: 10.1097/QAI.0000000000003139.
    >> Share

  272. BLAIR CS, Fulcher JA, Cho GD, Gorbach PM, et al
    Impact of Methamphetamine Use and Rectal STIs on Systemic and Rectal Mucosal Inflammation.
    J Acquir Immune Defic Syndr. 2022 Dec 14. doi: 10.1097/QAI.0000000000003143.
    >> Share

  273. WOLFE HL, Drainoni ML, Klasko-Foster L, Fix GM, et al
    Structural Equation Modeling of Stigma and HIV Prevention Clinical Services Among Transgender and Gender Diverse Adults: The Mediating Role of Substance Use and HIV Sexual Risk.
    J Acquir Immune Defic Syndr. 2022 Dec 14. doi: 10.1097/QAI.0000000000003144.
    >> Share

  274. VIGUERIE A, Song R, Johnson AS, Lyles CM, et al
    Isolating the effect of COVID-19 related disruptions on HIV diagnoses in the United States in 2020.
    J Acquir Immune Defic Syndr. 2022 Dec 14. doi: 10.1097/QAI.0000000000003140.
    >> Share

  275. ANTOINE M, Rubenstein E, Lascoux C, Chawki S, et al
    Clinical description of sixty-six cases of monkeypox virus (MKPV) infection among men who have sex with men (MSM), in an HIV/PrEP French Clinic.
    J Acquir Immune Defic Syndr. 2022 Dec 14. doi: 10.1097/QAI.0000000000003146.
    >> Share

  276. AJIBOLA G, Maswabi K, Hughes MD, Bennett K, et al
    Long-term clinical, immunologic, and virologic outcomes among early-treated children with HIV in Botswana: a nonrandomized controlled clinical trial.
    J Acquir Immune Defic Syndr. 2022 Dec 12. doi: 10.1097/QAI.0000000000003147.
    >> Share

  277. COTTINO MC, Kulig CE, Suh JS, Jimenez HR, et al
    Evaluation of Statin Prescribing Practices and Predictors of Statin Underutilization in Persons with HIV.
    J Acquir Immune Defic Syndr. 2022 Dec 12. doi: 10.1097/QAI.0000000000003141.
    >> Share

  278. STONER MCD, Kelly NK, Gomez-Olive FX, Kahn K, et al
    The relationships among stress-responsive biomarkers, ART adherence, and viral suppression among adolescent girls and young women living with HIV in South Africa: An HPTN 068 Analysis.
    J Acquir Immune Defic Syndr. 2022 Dec 12. doi: 10.1097/QAI.0000000000003149.
    >> Share

  279. TORRE P 3RD, Zhang ZJ, Hoffman HJ, Frederick T, et al
    Auditory Function in the Pediatric HIV/AIDS Cohort Study Adolescent Master Protocol (AMP) Up Young Adults: A Pilot Study.
    J Acquir Immune Defic Syndr. 2022 Dec 12. doi: 10.1097/QAI.0000000000003145.
    >> Share

  280. WEMBULUA BS, Valin N, Lambert-Niclot S, Nerozzi-Banfi E, et al
    APOBEC-induced mutations at initiation of cabotegravir + rilpivirine for two patients infected by HIV-1 subtype CRF02: The interest of systematic genotyping.
    J Acquir Immune Defic Syndr. 2022 Dec 12. doi: 10.1097/QAI.0000000000003148.
    >> Share

  281. TANNER MR, Zhu W, Iqbal K, Dominguez KL, et al
    HIV Pre-exposure Prophylaxis Services for Black and Hispanic or Latino Gay, Bisexual, and Other Men Who have Sex with Men and Transgender Women in THRIVE, 2015-2020.
    J Acquir Immune Defic Syndr. 2022 Dec 8. doi: 10.1097/QAI.0000000000003138.
    >> Share

  282. RAKHMANINA N, Richards K, Adeline Koay WL
    Transient Viremia in Young Adults with HIV Following the Switch to Long-Acting Cabotegravir and Rilpivirine: Considerations for Dosing Schedule and Monitoring.
    J Acquir Immune Defic Syndr. 2022 Dec 8. doi: 10.1097/QAI.0000000000003142.
    >> Share

  283. OLADELE TT, Olakunde BO, Mao W, Oladele EA, et al
    MOBILIZING DOMESTIC FUNDS FOR THE HIV/AIDS RESPONSE IN NIGERIA: ESTIMATING THE POTENTIAL CONTRIBUTION OF THE NATIONAL HEALTH INSURANCE SCHEME.
    J Acquir Immune Defic Syndr. 2022 Dec 6. doi: 10.1097/QAI.0000000000003136.
    >> Share

  284. SAROWAR A, Coffin CS, Fung S, Wong A, et al
    Brief Report: Effect of Antiretroviral Switch From Tenofovir Disoproxil fumarate to Tenofovir Alafenamide on Alanine Aminotransferase, Lipid Profiles, and Renal Function in HIV/HBV-Coinfected Individuals in a Nationwide Canadian Study.
    J Acquir Immune Defic Syndr. 2022;91:368-372.
    >> Share

  285. BUNTING SR, Feinstein BA, Calabrese SK, Hazra A, et al
    The Role of Social Biases, Race, and Condom Use in Willingness to Prescribe HIV Pre-exposure Prophylaxis to MSM: An Experimental, Vignette-Based Study.
    J Acquir Immune Defic Syndr. 2022;91:353-363.
    >> Share

    November 2022
  286. MATTHEWS RP, Zang X, Barrett SE, Koynov A, et al
    A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 Infection.
    J Acquir Immune Defic Syndr. 2022 Nov 29. doi: 10.1097/QAI.0000000000003135.
    >> Share

  287. MANSERGH G, Kota KK, Carnes N, Gelaude D, et al
    Refusal of Daily Oral PrEP: Implementation Considerations and Reported Likelihood of Using Various HIV Prophylaxis Products in a Diverse Sample of MSM.
    J Acquir Immune Defic Syndr. 2022 Nov 24. doi: 10.1097/QAI.0000000000003134.
    >> Share

  288. MILLER AP, Shoptaw S, Moucheraud C, Mvududu R, et al
    Recent alcohol use is associated with increased Pre-exposure Prophylaxis (PrEP) continuation and adherence among pregnant and post-partum women in South Africa.
    J Acquir Immune Defic Syndr. 2022 Nov 21. doi: 10.1097/QAI.0000000000003133.
    >> Share

  289. HAHN AW, Ruderman SA, Nance RM, Whitney BW, et al
    Vaporized Nicotine (E-cigarette) and Tobacco Smoking Among People with HIV: Use Patterns and Associations with Depression and Panic Symptoms.
    J Acquir Immune Defic Syndr. 2022 Nov 15. pii: 00126334-990000000-00151.
    >> Share

  290. SABERI P, Stoner MCD, Eskaf S, Ndukwe S, et al
    Preferences for HIV Treatment Formulations among Young Adults with HIV in the United States.
    J Acquir Immune Defic Syndr. 2022 Nov 7. pii: 00126334-990000000-00150.
    >> Share

  291. PIERRE DE VILLARTAY J, Pannier E, Sibiude J, Frange P, et al
    T Cell Receptor alpha repertoire diversity at birth after in utero exposure to HIV integrase strand-transfer inhibitors.
    J Acquir Immune Defic Syndr. 2022 Nov 7. pii: 00126334-990000000-00149.
    >> Share

  292. LINDSEY JC, Hudgens M, Gaur AH, Horvath KJ, et al
    Electronic dose monitoring device patterns in youth living with HIV enrolled in an adherence intervention clinical trial.
    J Acquir Immune Defic Syndr. 2022 Nov 7. doi: 10.1097/QAI.0000000000003126.
    >> Share

  293. STAITIEH BS, Malik S, Auld SC, Wigger GW, et al
    HIV Increases the Risk of Cigarette Smoke-Induced Emphysema via MMP-9.
    J Acquir Immune Defic Syndr. 2022 Nov 4. pii: 00126334-990000000-00141.
    >> Share

  294. GURLEY SA, Stupp PW, Fellows IE, Parekh BS, et al
    Estimation of HIV-1 Incidence Using a Testing History-Based method; analysis from the Population-based HIV Impact Assessment survey data in 12 African Countries.
    J Acquir Immune Defic Syndr. 2022 Nov 4. doi: 10.1097/QAI.0000000000003123.
    >> Share

  295. KALICHMAN SC, Eaton LA, Kalichman MO, Sam SS, et al
    Pre-Pandemic Predictors of Medication Adherence and HIV Viral Load During the First Year of COVID-19.
    J Acquir Immune Defic Syndr. 2022 Nov 3. doi: 10.1097/QAI.0000000000003129.
    >> Share

  296. BOGARD SN, Lee JT, Patel M, Kempker RR, et al
    Brief Report: Financial Burden of Toxoplasmosis Encephalitis Treatment at a Safety Net Hospital.
    J Acquir Immune Defic Syndr. 2022;91:276-279.
    >> Share

  297. SCHAAF REA, Verburgh ML, Boyd A, Wit FW, et al
    Change in Substance Use and the Effects of Social Distancing on Health-Related Quality of Life and Depressive Symptoms During the COVID-19 Pandemic in People Living With and Without HIV.
    J Acquir Immune Defic Syndr. 2022;91:261-268.
    >> Share

  298. CHYTEN-BRENNAN J, Patel VV, Anastos K, Hanna DB, et al
    Brief Report: Role of Gender-Affirming Hormonal Care in HIV Care Continuum Outcomes When Comparing Transgender Women With Cisgender Sexual Minority Men.
    J Acquir Immune Defic Syndr. 2022;91:255-260.
    >> Share

  299. WOODWARD R, Fadhil S, Kisigo G, O'Donnell P, et al
    Prehypertension and Retinal Arteriolar Narrowing in PWH in Tanzania.
    J Acquir Immune Defic Syndr. 2022;91:e6-e8.
    >> Share

  300. CHOW FC, Zhao F, He Y, Song X, et al
    Sex differences in the association between cerebrovascular function and cognitive health in people living with HIV in urban China.
    J Acquir Immune Defic Syndr. 2022 Nov 1. pii: 00126334-990000000-00143.
    >> Share

  301. EL-NAHAL WG, Chander G, Jones JL, Fojo AT, et al
    Telemedicine Use Among People with HIV in 2021: The Hybrid-Care Environment.
    J Acquir Immune Defic Syndr. 2022 Nov 1. doi: 10.1097/QAI.0000000000003124.
    >> Share

    October 2022
  302. GONZALEZ R, Nhampossa T, Figueroa-Romero A, Mendes A, et al
    SARS-CoV-2 seropositivity and HIV viral load among Mozambican pregnant women.
    J Acquir Immune Defic Syndr. 2022 Oct 24. pii: 00126334-990000000-00140.
    >> Share

  303. MORAR NS, Mansoor LE, Naidoo K, Katz AW, et al
    Male partner opinions of the dapivirine vaginal ring used during an open-label extension HIV prevention trial in KwaZulu-Natal, South Africa.
    J Acquir Immune Defic Syndr. 2022 Oct 19. pii: 00126334-990000000-00139.
    >> Share

  304. PALICH R, Agher R, Wetshikoy DJ, Cuzin L, et al
    Birth country influences the choice of antiretroviral therapy in HIV-infected individuals: experience from a French HIV centre.
    J Acquir Immune Defic Syndr. 2022 Oct 17. pii: 00126334-990000000-00138.
    >> Share

  305. MEDLEY A, Tsiouris F, Pals S, Senyana B, et al
    An Evaluation of an Enhanced Model of Integrating Family Planning into HIV Treatment Services in Zambia, April 2018 - June 2019.
    J Acquir Immune Defic Syndr. 2022 Oct 13. pii: 00126334-990000000-00135.
    >> Share

  306. COLEMAN JS, Diniz CP, Fuchs EJ, Marzinke MA, et al
    Interaction of Depot Medroxyprogesterone Acetate and Tenofovir Disoproxil Fumarate/Emtricitabine on Peripheral Blood Mononuclear Cells and Cervical Tissue Susceptibility to HIV Infection and Pharmacokinetics.
    J Acquir Immune Defic Syndr. 2022 Oct 13. pii: 00126334-990000000-00134.
    >> Share

  307. BELOV A, Yang H, Forshee RA, Whitaker BI, et al
    Modeling the Risk of HIV Transfusion Transmission.
    J Acquir Immune Defic Syndr. 2022 Oct 11. pii: 00126334-990000000-00129.
    >> Share

  308. SHITOLE SG, Naveed M, Wang Z, Wang T, et al
    Metabolomic Profiling of Cardiac Fibrosis and Steatosis in Women with or at risk for HIV.
    J Acquir Immune Defic Syndr. 2022 Oct 10. pii: 00126334-990000000-00133.
    >> Share

  309. LOPEZ JN, Prieto-Tato L, Escosa L, Bernardino JI, et al
    Pregnancy Outcomes Among Perinatally HIV-infected women in Spain.
    J Acquir Immune Defic Syndr. 2022 Oct 10. pii: 00126334-990000000-00131.
    >> Share

  310. O'GRADY TJ, Yuan Y, Harris JM, Massaroni RJ, et al
    Impact of COVID-19 on HIV Testing Among AIDS Institute Funded Providers in New York State - A Time Series Analysis.
    J Acquir Immune Defic Syndr. 2022 Oct 10. pii: 00126334-990000000-00132.
    >> Share

  311. MELVIN AJ, Yee KL, Gray KP, Yedla M, et al
    Pharmacokinetics, tolerability and safety of doravirine and doravirine/lamivudine/tenofovir disoproxil fumarate fixed dose combination tablets in adolescents living with HIV: Week 24 results from IMPAACT 2014.
    J Acquir Immune Defic Syndr. 2022 Oct 10. pii: 00126334-990000000-00136.
    >> Share

  312. JIANG W, Ronen K, Osborn L, Drake AL, et al
    Programmatic retention in prevention of mother-to-child transmission (PMTCT) programs: estimated rates and cofactors using different non-retention measures.
    J Acquir Immune Defic Syndr. 2022 Oct 7. pii: 00126334-990000000-00130.
    >> Share

  313. ESRA R, Carstens J, Le Roux S, Mabuto T, et al
    Validation and improvement of a machine learning model to predict interruptions in antiretroviral treatment in South Africa.
    J Acquir Immune Defic Syndr. 2022 Oct 3. pii: 00126334-990000000-00126.
    >> Share

  314. PAN Z, Dahman B, Bono RS, Sabik LM, et al
    Physician reimbursement and retention in HIV care: Racial disparities in the US South.
    J Acquir Immune Defic Syndr. 2022 Oct 3. pii: 00126334-990000000-00127.
    >> Share

  315. PEEBLES K, Brown ER, Hendrix CW, Palanee-Phillips T, et al
    Dapivirine ring HIV-1 prevention effectiveness for women engaged in vaginal and anal intercourse: insights from mathematical modeling.
    J Acquir Immune Defic Syndr. 2022 Oct 3. pii: 00126334-990000000-00128.
    >> Share

  316. ZHONG M, Chen C, Hu Y, Zou M, et al
    Efficacy and Safety of a Simplified Lamivudine Plus Dolutegravir Dual Therapy in HIV-1-Infected Patients: A Multicenter Cohort Study in China.
    J Acquir Immune Defic Syndr. 2022;91.
    >> Share

  317. YAN D, Wang Z, Wang Y, He S, et al
    Performance of Creatinine- and Cystatin C-Based Equations for Glomerular Filtration Rate Estimation in HIV-1-Infected Individuals Receiving Dolutegravir + Tenofovir Disoproxil Fumarate + Lamivudine as Initial Antiretroviral Therapy: A Retrospective Ob
    J Acquir Immune Defic Syndr. 2022;91.
    >> Share

  318. LI CL, Liang HY, Xiao J, Li R, et al
    The Effect of Pretreatment Potential Resistance to NNRTIs on Antiviral Therapy in Patients With HIV/AIDS.
    J Acquir Immune Defic Syndr. 2022;91.
    >> Share

  319. NIE J, Zeng Y, Zeng Q, Du X, et al
    Risk Factors for CSF/Plasma HIV-1 RNA Discordance in HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2022;91.
    >> Share

  320. ZHAO F, Rao M, Chen W, Cai K, et al
    Dolutegravir Plus Lamivudine Dual-Drug Regimen in Treatment-Naive HIV-1-Infected Patients With High-Level Viral Load: Preliminary Data From the Real World.
    J Acquir Immune Defic Syndr. 2022;91.
    >> Share

  321. SUN L, He Y, Xu L, Zhao F, et al
    Higher Risk of Dyslipidemia With Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide than Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate Among Antiretroviral-Naive People Living With HIV in China.
    J Acquir Immune Defic Syndr. 2022;91.
    >> Share

  322. TONGTONG Y, Shenghua H, Yin W, Lin C, et al
    Effectiveness and Safety of Dolutegravir Versus Efavirenz-Based Antiviral Regimen in People Living With HIV-1 in Sichuan Province of China: A Real-World Study.
    J Acquir Immune Defic Syndr. 2022;91.
    >> Share

  323. CAMPBELL CK, Ndukwe S, Dube K, Sauceda JA, et al
    Overcoming Challenges of Online Research: Measures to Ensure Enrollment of Eligible Participants.
    J Acquir Immune Defic Syndr. 2022;91:232-236.
    >> Share

  324. PATIL G, Mbewe EG, Kabundula PP, Smith H, et al
    Longitudinal Cognitive Outcomes in Children With HIV in Zambia: 2-Year Outcomes From the HIV-Associated Neurocognitive Disorders in Zambia (HANDZ) Study.
    J Acquir Immune Defic Syndr. 2022;91:217-225.
    >> Share

  325. GEANNOPOULOS K, McMahan C, Maldonado RS, Abbott A, et al
    Retinal Thinning in People With Well-Controlled HIV Infection.
    J Acquir Immune Defic Syndr. 2022;91:210-216.
    >> Share

  326. DUMCHEV K, Kiriazova T, Riabokon S, Shost A, et al
    Comparative Clinical Outcomes With Scale-up of Dolutegravir as First-Line Antiretroviral Therapy in Ukraine.
    J Acquir Immune Defic Syndr. 2022;91:197-209.
    >> Share

  327. DORWARD J, Naidoo J, Moodley P, Sookrajh Y, et al
    Diagnostic Accuracy of the Rapid Xpert HIV-1 Viral Load XC, Xpert HIV-1 Viral Load, & m-PIMA HIV-1/2 Viral Load in South African Clinics.
    J Acquir Immune Defic Syndr. 2022;91:189-196.
    >> Share

  328. CAPPARELLI EV, Ajibola G, Maswabi K, Holme MP, et al
    Safety and Pharmacokinetics of Intravenous 10-1074 and VRC01LS in Young Children.
    J Acquir Immune Defic Syndr. 2022;91:182-188.
    >> Share

  329. LAM JO, Leyden WA, Leong TK, Horberg MA, et al
    Variation in Heart Failure Risk by HIV Severity and Sex in People With HIV Infection.
    J Acquir Immune Defic Syndr. 2022;91:175-181.
    >> Share

  330. WOMACK JA, Murphy TE, Leo-Summers L, Bates J, et al
    Predictive Risk Model for Serious Falls Among Older Persons Living With HIV.
    J Acquir Immune Defic Syndr. 2022;91:168-174.
    >> Share

  331. ROSS RD, Olali AZ, Shi Q, Hoover DR, et al
    Brief Report: Undercarboxylated Osteocalcin Is Associated With Cognition in Women With and Without HIV.
    J Acquir Immune Defic Syndr. 2022;91:162-167.
    >> Share

  332. CZARNOGORSKI M, Benn P, McCoig C, Nwafor T, et al
    Brief Report: Impact of COVID-19 on Cabotegravir Plus Rilpivirine Long-Acting Dosing Across 6 Ongoing Global Phase IIb and III Clinical Trials.
    J Acquir Immune Defic Syndr. 2022;91:157-161.
    >> Share

  333. GOEDEL WC, Rogers BG, Li Y, Nunn AS, et al
    Pre-exposure Prophylaxis Discontinuation During the COVID-19 Pandemic Among Men Who Have Sex With Men in a Multisite Clinical Cohort in the United States.
    J Acquir Immune Defic Syndr. 2022;91:151-156.
    >> Share

  334. MORGAN E, Caba AE, Eaton LA, Watson RJ, et al
    PrEP Access Affected by COVID-19 Is Associated With Increased Odds of HIV Seroconversion.
    J Acquir Immune Defic Syndr. 2022;91:138-143.
    >> Share

  335. BEESHAM I, Parikh UM, Mellors JW, Joseph Davey DL, et al
    High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study.
    J Acquir Immune Defic Syndr. 2022;91:130-137.
    >> Share

  336. MCCLYMONT E, Faber MT, Lindquist S, Bone JN, et al
    Human Papillomavirus Infection Among Pregnant Women Living With HIV: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2022;91:122-129.
    >> Share

  337. PATEL D, Williams WO, Wright C, Taylor-Aidoo N, et al
    HIV Testing Services Outcomes in CDC-Funded Health Departments During COVID-19.
    J Acquir Immune Defic Syndr. 2022;91:117-121.
    >> Share

    September 2022
  338. NEVREKAR N, Butler K, Shapiro DE, Atuhaire P, et al
    Self-Reported Antiretroviral Adherence: Association with Maternal Viral Load Suppression in Postpartum Women Living with HIV-1 from Promoting Maternal and Infant Survival Everywhere (PROMISE), a Randomized Controlled Trial in Sub-Saharan Africa and In
    J Acquir Immune Defic Syndr. 2022 Sep 28. pii: 00126334-990000000-00117.
    >> Share

  339. CRANMER LM, Njuguna IN, LaCourse SM, Figueroa J, et al
    Performance of Tuberculosis symptom screening among hospitalized ART-naive Children with HIV in Kenya.
    J Acquir Immune Defic Syndr. 2022 Sep 26. pii: 00126334-990000000-00123.
    >> Share

  340. WANG G, Song W, Rao S, Heitgerd J, et al
    HIV Positivity, Linkage to Medical Care, Interview for Partner Services, and Pre-exposure Prophylaxis Awareness and Referral among Men Who Have Sex with Men Tested in Non-healthcare Settings in the United States, 2019.
    J Acquir Immune Defic Syndr. 2022 Sep 26. pii: 00126334-990000000-00125.
    >> Share

  341. VYAS KJ, Marconi VC, Moanna A, Rimland D, et al
    Trends in Cause-Specific Mortality among Veterans with HIV: A 35-Year (1982-2016) Analysis of the HIV Atlanta VA Cohort Study.
    J Acquir Immune Defic Syndr. 2022 Sep 26. pii: 00126334-990000000-00124.
    >> Share

  342. CHAMMARTIN F, Darling K, Abela IA, Battegay M, et al
    CD4:CD8 ratio and CD8 cell count and their prognostic relevance for coronary heart disease events and stroke in antiretroviral treated individuals: The Swiss HIV Cohort Study.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00116.
    >> Share

  343. LEMON TL, Tassiopoulos K, Tsai AC, Cantos K, et al
    Health insurance coverage, clinical outcomes, and health-related quality of life among youth born to women living with HIV.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00120.
    >> Share

  344. PALELLA FJ, Hou Q, Li J, Mahnken J, et al
    Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00121.
    >> Share

  345. MOORE DM, Nanfuka M, Zhang W, Okoboi S, et al
    Limited impact of first-line drug resistance mutations on virologic response among patients receiving second-line anti-retroviral therapy in rural Uganda.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00118.
    >> Share

  346. JACKA BP, Nolen S, Bessey S, Zang X, et al
    Use of pre-exposure prophylaxis (PrEP) to prevent rapid HIV transmission among people who inject drugs (PWID) in rural counties in the United States: A modeling study.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00122.
    >> Share

  347. ADEBAJO SB, Adebiyi R, Chama J, Bello S, et al
    Depression and Sexual Stigma are Associated with Cardiometabolic Risk among Sexual and Gender Minorities Living with HIV in Nigeria.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00119.
    >> Share

  348. BODLEY N, Dorward J, Naidoo J, Letsoalo M, et al
    Diagnostic accuracy of the Alere Afinion AS100 point-of-care assay to screen for non-communicable diseases amongst people living with HIV.
    J Acquir Immune Defic Syndr. 2022 Sep 20. pii: 00126334-990000000-00115.
    >> Share

  349. FAINI D, Msafiri F, Munseri P, Bakari M, et al
    The prevalence, incidence and risk factors for HIV among female sex workers - a cohort being prepared for a phase IIb HIV vaccine trial in Dar es Salaam, Tanzania.
    J Acquir Immune Defic Syndr. 2022 Sep 20. pii: 00126334-990000000-00113.
    >> Share

  350. BOURGI K, Ofner S, Musick B, Griffith B, et al
    Weight Gain among Treatment-naive Persons with HIV Receiving Dolutegravir in Kenya.
    J Acquir Immune Defic Syndr. 2022 Sep 20. pii: 00126334-990000000-00114.
    >> Share

  351. HARRIS RM, Xavier Hall CD, Mills JC, Pence BW, et al
    Beyond viral suppression - The impact of cumulative violence on health-related quality of life among a cohort of virally suppressed patients.
    J Acquir Immune Defic Syndr. 2022 Sep 12. pii: 00126334-990000000-00112.
    >> Share

  352. NYAKATO P, Christ B, Anderegg N, Muhairwe J, et al
    High unreported mortality in children and youth (<25 years) living with HIV who were lost to care from antiretroviral therapy programs in Southern Africa: results from a multi-country tracing study.
    J Acquir Immune Defic Syndr. 2022 Sep 9. pii: 00126334-990000000-00108.
    >> Share

  353. OPSTEEN S, Moylan D, Taiwo BO, Robertson KR, et al
    Intracellular cystatin B levels are altered in HIV-infected participants with respect to neurocognitive status and anti-retroviral therapy.
    J Acquir Immune Defic Syndr. 2022 Sep 9. pii: 00126334-990000000-00107.
    >> Share

  354. XIA Q, Maduro GA, Li W, Huynh M, et al
    Life expectancy among people with HIV in New York City, 2009-2018.
    J Acquir Immune Defic Syndr. 2022 Sep 8. pii: 00126334-990000000-00109.
    >> Share

  355. MORRIS SR, Jain S, Blumenthal J, Bolan R, et al
    Randomized Trial of Individualized Texting for Adherence Building (iTAB) plus Motivational Interviewing for PrEP Adherence in Transgender Individuals (The iM-PrEPT Study).
    J Acquir Immune Defic Syndr. 2022 Sep 8. pii: 00126334-990000000-00110.
    >> Share

  356. LECHIILE K, Leeme TB, Tenforde MW, Bapabi M, et al
    Laboratory Evaluation of the VISITECT(R) Advanced Disease Semi-quantitative Point-of-care CD4 Test.
    J Acquir Immune Defic Syndr. 2022 Sep 8. pii: 00126334-990000000-00111.
    >> Share

  357. ARENS Y, Bilker WB, Han X, Plankey M, et al
    HIV Infection Does Not Explain Higher Nicotine Metabolism in People Living with HIV.
    J Acquir Immune Defic Syndr. 2022 Sep 5. pii: 00126334-990000000-00106.
    >> Share

  358. DRUMMOND MB, Edmonds A, Ramirez C, Stosor V, et al
    Association between HIV and prevalence and manifestations of asthma: Analysis of the Multicenter AIDS Cohort Study and Women's Interagency HIV Study.
    J Acquir Immune Defic Syndr. 2022 Sep 5. pii: 00126334-990000000-00105.
    >> Share

  359. RAMOS MI, Prieto Tato LM, Martin SG, Gomez MLN, et al
    Clinical and epidemiologic characteristics of a cohort of HIV-infected mother-infant pairs during 21 years.
    J Acquir Immune Defic Syndr. 2022 Sep 2. pii: 00126334-990000000-00104.
    >> Share

  360. CAMPBELL DM, Cowlings PD, Tholanah M, Robinson MJ, et al
    "In diversity there is beauty and there is strength." -Dr. Maya Angelou A Community Call to Action to Prioritize Inclusion and Enrollment of Women in HIV Cure-Related Research.
    J Acquir Immune Defic Syndr. 2022 Sep 2. pii: 00126334-990000000-00103.
    >> Share

  361. CHENCINER L, Symonds M, Dissanayake O, Hunter A, et al
    Lymphocyte-CRP Ratio and CRP-Albumin Ratio as Potential Inflammation Markers in Adults With HIV.
    J Acquir Immune Defic Syndr. 2022;91:e1-e3.
    >> Share

  362. SOLANKE T, Kamau F, Esterhuizen T, Maartens G, et al
    Concentrations of Efavirenz, Tenofovir, and Emtricitabine in Obesity: A Cross-Sectional Study.
    J Acquir Immune Defic Syndr. 2022;91:101-108.
    >> Share

  363. MOLINA JM, Yazdanpanah Y, Afani Saud A, Bettacchi C, et al
    Brief Report: Efficacy and Safety of Oral Islatravir Once Daily in Combination With Doravirine Through 96 Weeks for Treatment-Naive Adults With HIV-1 Infection Receiving Initial Treatment With Islatravir, Doravirine, and Lamivudine.
    J Acquir Immune Defic Syndr. 2022;91:68-72.
    >> Share

  364. LEWIS MA, Harshbarger C, Bann C, Marconi VC, et al
    Effectiveness of an Interactive, Highly Tailored "Video Doctor" Intervention to Suppress Viral Load and Retain Patients With HIV in Clinical Care: A Randomized Clinical Trial.
    J Acquir Immune Defic Syndr. 2022;91:58-67.
    >> Share

  365. BEESHAM I, Mansoor LE, Joseph Davey DL, Palanee-Phillips T, et al
    Brief Report: Quantifiable Plasma Tenofovir Among South African Women Using Daily Oral Pre-exposure Prophylaxis During the ECHO Trial.
    J Acquir Immune Defic Syndr. 2022;91:26-30.
    >> Share

  366. KAMIRE V, Magut F, Khagayi S, Kambona C, et al
    HIV Risk Factors and Risk Perception Among Adolescent Girls and Young Women: Results From a Population-Based Survey in Western Kenya, 2018.
    J Acquir Immune Defic Syndr. 2022;91:17-25.
    >> Share

  367. LLIBRE JM, Lopez Cortes LF, Aylott A, Wynne B, et al
    Brief Report: Evaluation of Inflammation and Atherogenesis Biomarkers Through 148 Weeks Postswitch to Dolutegravir and Rilpivirine in SWORD-1/SWORD-2.
    J Acquir Immune Defic Syndr. 2022;91:73-78.
    >> Share

  368. COUTINHO CM, Warshaw MG, Duarte G, Stek A, et al
    Effects of initiating raltegravir-based versus efavirenz-based antiretroviral regimens during pregnancy on weight changes and perinatal outcomes: NICHD P1081.
    J Acquir Immune Defic Syndr. 2022 Sep 1. pii: 00126334-990000000-00100.
    >> Share

    August 2022
  369. COBURN SB, Lang R, Zhang J, Palella FJ, et al
    Statins utilization in adults with HIV: The treatment gap and predictors of statin initiation.
    J Acquir Immune Defic Syndr. 2022 Aug 31. pii: 00126334-990000000-00102.
    >> Share

  370. MUYINDIKE WR, Fatch R, Cheng DM, Emenyonu NI, et al
    Unhealthy Alcohol Use is Associated with sub-Optimal Adherence to Isoniazid Preventive Therapy in Persons with HIV in southwestern Uganda.
    J Acquir Immune Defic Syndr. 2022 Aug 30. pii: 00126334-990000000-00101.
    >> Share

  371. SINGH P, Moulton LH, Barnes GL, Gupta A, et al
    Pregnancy in Women with HIV in a Tuberculosis Preventive Therapy Trial.
    J Acquir Immune Defic Syndr. 2022 Aug 24. pii: 00126334-990000000-00099.
    >> Share

  372. MATHUR P, Kottilil S, Pallikkuth S, Frasca D, et al
    Persistent CD38 expression on CD8+ T lymphocytes contributes to altered mitochondrial function and chronic inflammation in people with HIV, despite ART.
    J Acquir Immune Defic Syndr. 2022 Aug 24. pii: 00126334-990000000-00098.
    >> Share

  373. CALZA L, Bon I, Pensalfine G, Vitale S, et al
    CHANGES IN SERUM INFLAMMATORY MARKERS IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED PATIENTS STARTING DOLUTEGRAVIR/LAMIVUDINE OR TENOFOVIR ALAFENAMIDE/EMTRICITABINE/BICTEGRAVIR.
    J Acquir Immune Defic Syndr. 2022 Aug 18. pii: 00126334-990000000-00095.
    >> Share

  374. DRAGONI F, Rossetti B, Lombardi F, Raffaelli CS, et al
    Dynamics of total and intact HIV-1 DNA in virologically suppressed patients switching to DTG- or ATV-based dual therapy.
    J Acquir Immune Defic Syndr. 2022 Aug 15. pii: 00126334-990000000-00092.
    >> Share

  375. JIAMSAKUL A, Gani Y, Avihingsanon A, Azwa I, et al
    Mortality after loss to follow-up - a linkage study of people living with HIV in Thailand and Malaysia.
    J Acquir Immune Defic Syndr. 2022 Aug 15. pii: 00126334-990000000-00094.
    >> Share

  376. STEINERT JI, Shenderovich Y, Smith M, Zhou S, et al
    Economic wellbeing and associated mediating pathways to improved antiretroviral therapy adherence among adolescents living with HIV: A prospective cohort study in South Africa.
    J Acquir Immune Defic Syndr. 2022 Aug 15. pii: 00126334-990000000-00091.
    >> Share

  377. ANDERSON AM, Bhondoekhan F, Curanovic D, Connelly MA, et al
    Higher soluble CD163 in blood is associated with significant depression symptoms in men with HIV.
    J Acquir Immune Defic Syndr. 2022 Aug 15. pii: 00126334-990000000-00093.
    >> Share

  378. TSENG AS, Sambai B, Monroe-Wise A, Mbogo LW, et al
    Assisted partner services for people who inject drugs: Index characteristics associated with untreated HIV in partners.
    J Acquir Immune Defic Syndr. 2022 Aug 15. pii: 00126334-990000000-00089.
    >> Share

  379. GROENENDIJK AL, Vos WAJW, Dos Santos JC, Rokx C, et al
    Non-AIDS-events in individuals with spontaneous control of HIV-1: a systematic review.
    J Acquir Immune Defic Syndr. 2022 Aug 15. pii: 00126334-990000000-00090.
    >> Share

  380. YOON H, Hemmige VS, Lee A, Conway-Pearson LS, et al
    Cryptococcal antigen screening and missed opportunities for earlier diagnosis among people with HIV and poor virologic control in the Bronx, N.Y.
    J Acquir Immune Defic Syndr. 2022 Aug 11. pii: 00126334-990000000-00087.
    >> Share

  381. NEMATADZIRA TG, Murnane PM, Odiase OJ, Bacchetti P, et al
    ANTIRETROVIRAL THERAPY ADHERENCE DURING AND POST BREASTFEEDING CESSATION MEASURED BY TENOFOVIR LEVELS IN HAIR.
    J Acquir Immune Defic Syndr. 2022 Aug 11. pii: 00126334-990000000-00086.
    >> Share

  382. WEISS F, von Both U, Rack-Hoch A, Sollinger F, et al
    HIV-Positive and Breastfeeding in High-Income Settings: 5-year Experience from a Perinatal Center in Germany.
    J Acquir Immune Defic Syndr. 2022 Aug 9. pii: 00126334-990000000-00088.
    >> Share

  383. ESBER A, Dear N, Shah N, Kibuuka H, et al
    Virologic impact of the dolutegravir transition: prospective results from the multinational African Cohort Study.
    J Acquir Immune Defic Syndr. 2022 Aug 3. pii: 00126334-990000000-00084.
    >> Share

    July 2022
  384. VAUGHAN J, Perner Y, Wiggill T
    Diffuse Large B-cell Lymphoma in the public-sector of Johannesburg, South Africa, in the era of widescale Anti-retroviral therapy use.
    J Acquir Immune Defic Syndr. 2022 Jul 29. pii: 00126334-990000000-00082.
    >> Share

  385. GUPTA R, Hussain S, Hariprasad R, Dhanasekaran K, et al
    Concurrent cervical and anal high-risk human papillomavirus infection in women living with HIV: an observational case-control study.
    J Acquir Immune Defic Syndr. 2022 Jul 29. pii: 00126334-990000000-00083.
    >> Share

  386. TIEOSAPJAROEN W, Fairley CK, Eric CPF, Ivette A, et al
    Preferences for weight gain compared with other antiretroviral therapy side effects in people living with HIV: a discrete choice experiment.
    J Acquir Immune Defic Syndr. 2022 Jul 21. pii: 00126334-990000000-00079.
    >> Share

  387. WENDT CH, Samorodnitsky S, Lock EF, Kruk M, et al
    The lung and plasma metabolome in HIV-associated obstructive lung disease (OLD).
    J Acquir Immune Defic Syndr. 2022 Jul 15. pii: 00126334-990000000-00080.
    >> Share

  388. BROWN LK, Baltrusaitis K, Kennard BD, Emslie GJ, et al
    Forty-eight Week Outcomes of a Site-Randomized Trial of Combined Cognitive Behavioral Therapy and Medication Management Algorithm for Treatment of Depression Among Youth with HIV in the United States.
    J Acquir Immune Defic Syndr. 2022 Jul 15. pii: 00126334-990000000-00081.
    >> Share

  389. BRUZZESI E, Galli L, Poli A, Bossolasco S, et al
    PREVALENCE AND RISK FACTORS OF ANAL HPV INFECTION IN MSM LIVING WITH HIV: IDENTIFYING THE TARGET GROUPS TO PRIORITIZE FOR IMMUNIZATION.
    J Acquir Immune Defic Syndr. 2022 Jul 11. pii: 00126334-900000000-95605.
    >> Share

  390. LI DH, Benbow N, Keiser B, Mongrella M, et al
    Determinants of Implementation for HIV Pre-exposure Prophylaxis Based on an Updated Consolidated Framework for Implementation Research: A Systematic Review.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  391. JONES J, Knox J, Meanley S, Yang C, et al
    Explorations of the Role of Digital Technology in HIV-Related Implementation Research: Case Comparisons of Five Ending the HIV Epidemic Supplement Awards.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  392. RODRIGUEZ-HART C, Mackson G, Belanger D, West N, et al
    Reducing Intersecting Stigmas in HIV Service Organizations: An Implementation Science Model.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  393. GARNER BR, Knudsen HK, Zulkiewicz BA, Tueller SJ, et al
    The Setting-Intervention Fit of Nine Evidence-Based Interventions for Substance Use Disorders Within HIV Service Organizations Across the United States: Results of a National Stakeholder-Engaged Real-Time Delphi Study.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  394. STUMP TK, Ethier K, Hirschhorn LR, Dakin A, et al
    Development of an Implementation Facilitation Strategy to Link Mental Health Screening and eHealth Intervention for Clients in Ryan White-Funded Clinics in Chicago.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  395. SANCHEZ AL, Hoskins K, Pettit AR, Momplaisir F, et al
    Stakeholder Perspectives on MAPS.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  396. HARKNESS A, Wawrzyniak AJ, Kolber MA, Villamizar K, et al
    Multilevel Determinants of Rapid Antiretroviral Treatment Implementation and Demand in Miami-Dade County.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  397. DRABO EF, Moucheraud C, Nguyen A, Garland WH, et al
    Using Microsimulation Modeling to Inform EHE Implementation Strategies in Los Angeles County.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  398. CREGER T, Burgan K, Turner WH, Tarrant A, et al
    Using Implementation Mapping to Ensure the Success of PrEP Optimization Through Enhanced Continuum Tracking (PrOTECT) AL-A Structural Intervention to Track the Statewide PrEP Care Continuum in Alabama.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  399. CORNELI A, Perry B, Wilson J, Reif S, et al
    Identification of Determinants and Implementation Strategies to Increase PrEP Uptake Among Black Same Gender-Loving Men in Mecklenburg County, North Carolina: The PrEP-MECK Study.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  400. JOHNSON AK, Pyra M, Devlin S, Uvin AZ, et al
    Provider Perspectives on Factors Affecting the PrEP Care Continuum Among Black Cisgender Women in the Midwest United States: Applying the Consolidated Framework for Implementation Research.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  401. USKUP DK, Nieto O, Rosenberg-Carlson E, Lee SJ, et al
    Acceptability and Appropriateness of Digital PrEP Interventions for Black and Latina Cisgender Women: Perspectives From Service Providers in Los Angeles County.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  402. SONALKAR S, McAllister A, Kete C, Fishman J, et al
    Implementation of an HIV Pre-exposure Prophylaxis Strategy Into Abortion and Early Pregnancy Loss Care.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  403. FARO EZ, Mantell JE, Gonzalez-Argoti T, Hoffman S, et al
    Implementing PrEP Services in Diverse Health Care Settings.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  404. KING K, Balan S, Kanamori M, Shrader CH, et al
    Feasibility and Acceptability of HIV Self-Test Kit Distribution Through PrEP Clients' Social and Sexual Networks to Increase HIV Testing and PrEP Information.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  405. TSUYUKI K, Stockman JK, Stadnick NA, Moore V, et al
    Proyecto Compadre: Using Implementation Science to Tailor Peer Navigation for Latino Men in the US-Mexico Border Region.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  406. WOOD SM, Meanley S, Bonett S, Torres ME, et al
    Strengthening HIV Prevention Services Through an Implementation Science Approach: Perspectives From the HIV Testers in Philadelphia.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  407. FIELDS EL, Thornton N, Huettner S, Schumacher C, et al
    Safe Spaces 4 Sexual Health: A Status-Neutral, Mobile Van, HIV/STI Testing Intervention Using Online Outreach to Reach MSM at High Risk for HIV Acquisition or Transmission.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  408. NAAR S, MacDonell K, Chapman J, Todd L, et al
    Tailored Motivational Interviewing in Adolescent HIV Clinics: Primary Outcome Analysis of a Stepped Wedge Implementation Trial.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  409. RAJABIUN S, Killion K, Lennon-Dearing R, Williams BB, et al
    Using Implementation Science to Promote Integration and Sustainability of Community Health Workers in the HIV Workforce.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  410. PETTIT AC, Pichon LC, Ahonkhai AA, Robinson C, et al
    Comprehensive Process Mapping and Qualitative Interviews to Inform Implementation of Rapid Linkage to HIV Care Programs in a Mid-Sized Urban Setting in the Southern United States.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  411. HARRISON SE, Muessig K, Poteat T, Koester K, et al
    Addressing Racism's Role in the US HIV Epidemic: Qualitative Findings From Three Ending the HIV Epidemic Prevention Projects.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  412. BERES LK, Schwartz S, Mody A, Geng EH, et al
    Five Common Myths Limiting Engagement in HIV-Related Implementation Research.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  413. SCHWARTZ SR, Chavez Ortiz J, Smith JD, Beres LK, et al
    Data Velocity in HIV-Related Implementation Research: Estimating Time From Funding to Publication.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  414. QUEIROZ A, Mongrella M, Keiser B, Li DH, et al
    Profile of the Portfolio of NIH-Funded HIV Implementation Research Projects to Inform Ending the HIV Epidemic Strategies.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  415. PURCELL DW, Namkung Lee A, Dempsey A, Gordon C, et al
    Enhanced Federal Collaborations in Implementation Science and Research of HIV Prevention and Treatment.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  416. GLENSHAW MT, Gaist P, Wilson A, Cregg RC, et al
    Role of NIH in the Ending the HIV Epidemic in the US Initiative: Research Improving Practice.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  417. MUSTANSKI B, Smith JD, Keiser B, Li DH, et al
    Supporting the Growth of Domestic HIV Implementation Research in the United States Through Coordination, Consultation, and Collaboration: How We Got Here and Where We Are Headed.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  418. ODAYAR J, Chi BH, Phillips TK, Mukonda E, et al
    Transfer of Patients on Antiretroviral Therapy Attending Primary Health Care Services in South Africa.
    J Acquir Immune Defic Syndr. 2022;90:309-315.
    >> Share

    June 2022
  419. ARORA AK, Lessard D, Dube K, Lebouche B, et al
    It's Time to Embed Health-related Quality of Life across all Steps of the HIV Care Cascade.
    J Acquir Immune Defic Syndr. 2022 Jun 30. pii: 00126334-990000000-00071.
    >> Share

    May 2022
  420. BALASUBRAMANIAN R, Kasaie P, Schnure M, Dowdy DW, et al
    PROJECTED IMPACT OF EXPANDED LONG-ACTING INJECTABLE PREP USE AMONG MEN WHO HAVE SEX WITH MEN ON LOCAL HIV EPIDEMICS.
    J Acquir Immune Defic Syndr. 2022 May 30. pii: 00126334-990000000-00055.
    >> Share

  421. KIWEEWA FM, Tierney C, Butler K, Peters MG, et al
    Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women with HIV/ HBV Co-infection.
    J Acquir Immune Defic Syndr. 2022 May 27. pii: 00126334-990000000-00050.
    >> Share

  422. EL-NAHAL WG, Shen NM, Keruly JC, Jones JL, et al
    Time Between Viral Loads for People with HIV during the COVID-19 Pandemic.
    J Acquir Immune Defic Syndr. 2022 May 26. pii: 00126334-990000000-00051.
    >> Share

  423. KHERABI Y, de Castro N, Sellier PO, Hamet G, et al
    Efficacy and safety of efavirenz, raltegravir and dolutegravir in HIV-1/TB co-infection. A multicenter retrospective cohort study in France.
    J Acquir Immune Defic Syndr. 2022 May 26. pii: 00126334-990000000-00052.
    >> Share

  424. JONES DL, Zhang Y, Rodriguez VJ, Haberlen S, et al
    Association of PTSD with Longitudinal COVID-19 Burden in a Mixed-Serostatus Cohort of Men and Women: Weathering the Storm.
    J Acquir Immune Defic Syndr. 2022 May 19. pii: 00126334-990000000-00048.
    >> Share

  425. JAWA R, Walley AY, Wilson DJ, Green TC, et al
    Prescribe to Save Lives: Improving buprenorphine prescribing among HIV clinicians.
    J Acquir Immune Defic Syndr. 2022 May 18. pii: 00126334-990000000-00047.
    >> Share

  426. GARNER BR, Burrus O, Ortiz A, Tueller SJ, et al
    A longitudinal mixed-methods examination of Positive Health Check: Implementation results from a type 1 effectiveness-implementation hybrid trial.
    J Acquir Immune Defic Syndr. 2022 May 18. pii: 00126334-990000000-00044.
    >> Share

  427. HILL BJ, Motley DN, Rosentel K, VandeVusse A, et al
    Employment as HIV prevention: An employment support intervention for adolescent men who have sex with men and adolescent transgender women of color.
    J Acquir Immune Defic Syndr. 2022 May 12. pii: 00126334-990000000-00045.
    >> Share

  428. NDENKEH JN, Bowring AL, Njindam IM, Folem RD, et al
    HIV pre-exposure prophylaxis uptake and continuation among key populations in Cameroon: Lessons learned from the CHAMP program.
    J Acquir Immune Defic Syndr. 2022 May 10. pii: 00126334-990000000-00043.
    >> Share

  429. USSERY F, Bachanas P, Alwano MG, Lebelonyane R, et al
    HIV incidence in Botswana rural communities with high antiretroviral treatment coverage: Results from the Botswana Combination Prevention Project, 2013-2017.
    J Acquir Immune Defic Syndr. 2022 May 6. pii: 00126334-990000000-00042.
    >> Share

  430. HAMILTON DT, Agutu C, Babigumira JB, van der Elst E, et al
    Modeling the Impact of HIV-1 Nucleic Acid Testing among Symptomatic Adult Outpatients in Kenya.
    J Acquir Immune Defic Syndr. 2022 May 4. pii: 00126334-990000000-00040.
    >> Share

  431. ROY CARDINAL MH, Durand M, Chartrand-Lefebvre C, Soulez G, et al
    Associative prediction of carotid artery plaques based on ultrasound strain imaging and cardiovascular risk factors in people living with HIV and age-matched control subjects of the CHACS cohort.
    J Acquir Immune Defic Syndr. 2022 May 4. pii: 00126334-990000000-00041.
    >> Share

  432. SEVELIUS JM, Dilworth SE, Reback CJ, Chakravarty D, et al
    Randomized Controlled Trial of Healthy Divas: A Gender-Affirming, Peer-Delivered Intervention to Improve HIV Care Engagement among Transgender Women Living with HIV.
    J Acquir Immune Defic Syndr. 2022 May 3. pii: 00126334-990000000-00039.
    >> Share

  433. HECHTER RC, Bruxvoort KJ, Zhou H, Towner WJ, et al
    Sexually transmitted infections among men and transgender women using HIV pre-exposure prophylaxis in a large integrated health system- a cohort study.
    J Acquir Immune Defic Syndr. 2022 May 2. pii: 00126334-990000000-00038.
    >> Share

  434. MCMAHON DE, Chemtai L, Grant M, Singh R, et al
    Understanding Diagnostic Delays for Kaposi Sarcoma in Kenya: A Qualitative Study.
    J Acquir Immune Defic Syndr. 2022 May 2. pii: 00126334-990000000-00037.
    >> Share

  435. KOBAYASHI M, Matanock A, Xing W, Adih WK, et al
    Impact of 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease Among Adults With HIV-United States, 2008-2018.
    J Acquir Immune Defic Syndr. 2022;90:6-14.
    >> Share

    April 2022
  436. CANNON CA, Ramchandani MS, Buskin S, Dombrowski J, et al
    Previous Pre-Exposure Prophylaxis Use Among Men Who Have Sex with Men Newly Diagnosed with HIV Infection in King County, Washington.
    J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00035.
    >> Share

  437. WOOD BR, Bauer K, Lechtenberg R, Buskin SE, et al
    Direct and indirect effects of a Project ECHO longitudinal clinical tele-mentoring program on viral suppression for persons with HIV: a population-based analysis.
    J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00033.
    >> Share

  438. CLOSSON K, Lee M, Gibbs A, Nicholson V, et al
    Sexual relationship power equity is associated with consistent condom use and fewer experiences of recent violence among women living with HIV in Canada.
    J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00036.
    >> Share

  439. NEARY J, Bulterys MA, Ogutu EA, O'Malley G, et al
    Pediatric saliva-based HIV testing: healthcare worker and caregiver acceptability.
    J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00032.
    >> Share

  440. RAMCHANDANI MS, Berzkalns A, Cannon CA, Dombrowski JC, et al
    A De-medicalized Model to Provide PrEP in a Sexual Health Clinic.
    J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00034.
    >> Share

  441. KWAPONG YA, Sharma G, Shade JK, Piggott DA, et al
    Effect of HIV Serostatus on ICU Admission and Mortality among Hospitalized Coronavirus Disease 2019 (COVID-19) Patients.
    J Acquir Immune Defic Syndr. 2022 Apr 28. pii: 00126334-990000000-00031.
    >> Share

  442. ZEWDIE K, Kiptinness C, Ngure K, Kipkurui N, et al
    Targeted implementation of HIV self-testing increases testing uptake among partners of index persons known to have HIV in Kenya.
    J Acquir Immune Defic Syndr. 2022 Apr 27. pii: 00126334-990000000-00030.
    >> Share

  443. JOHNSTON CD, Siegler EL, Rice MC, Derry-Vick HM, et al
    Plasma Cell-Free Mitochondrial DNA as a Marker of Geriatric Syndromes in Older Adults with HIV.
    J Acquir Immune Defic Syndr. 2022 Apr 26. pii: 00126334-990000000-00029.
    >> Share

  444. SCHROTER J, Anelone AJN, de Boer RJ
    Quantification of CD4 Recovery in Early-Treated Infants Living With HIV.
    J Acquir Immune Defic Syndr. 2022;89:546-557.
    >> Share

  445. RESCH SC, Foote JHA, Wirth KE, Lasry A, et al
    Health impact and cost-effectiveness of HIV testing, linkage, and early antiretroviral treatment in the Botswana Combination Prevention Project.
    J Acquir Immune Defic Syndr. 2022 Apr 14. pii: 00126334-990000000-00021.
    >> Share

  446. MONTGOMERY ET, Roberts ST, Reddy K, Tolley EE, et al
    The CHARISMA randomized controlled trial: a relationship-focused counseling intervention integrated within oral PrEP delivery for HIV prevention among women in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2022 Apr 13. pii: 00126334-990000000-00025.
    >> Share

  447. OVERTON ET, Weir IR, Zanni MV, Fischinger S, et al
    Asymptomatic SARS-CoV-2 Infection is Common among ART-treated People with HIV.
    J Acquir Immune Defic Syndr. 2022 Apr 12. pii: 00126334-990000000-00027.
    >> Share

  448. OLIVIERI-MUI B, Shi S, McCarthy EP, Montano M, et al
    Categorizing comorbid risk for people living with HIV: a latent profile analysis.
    J Acquir Immune Defic Syndr. 2022 Apr 12. pii: 00126334-990000000-00028.
    >> Share

  449. ANDERSON MA, Chimbetete C, Shamu T, Dahwa R, et al
    "Validation of the D:A:D Chronic Kidney Disease Risk Score Incorporating Proteinuria in People Living with HIV in Harare, Zimbabwe".
    J Acquir Immune Defic Syndr. 2022 Apr 12. pii: 00126334-990000000-00026.
    >> Share

  450. LUO G, Su L, Hu Y, Zhou Y, et al
    The impact of COVID-19 restrictions on online sales of HIV self-test kits and implications for HIV prevention: analysis of transaction data from a leading e-commerce platform in China.
    J Acquir Immune Defic Syndr. 2022 Apr 8. pii: 00126334-990000000-00023.
    >> Share

  451. LARSEN AM, Osborn L, Ronen K, Richardson BA, et al
    Trajectories of depression symptoms from pregnancy through 24 months postpartum among Kenyan women living with HIV.
    J Acquir Immune Defic Syndr. 2022 Apr 8. pii: 00126334-990000000-00024.
    >> Share

  452. KHALIFA A, Findley S, Gummerson E, Mantell JE, et al
    Associations between mobility, food insecurity and transactional sex among women in cohabitating partnerships: an analysis from six African countries 2016-2017.
    J Acquir Immune Defic Syndr. 2022 Apr 6. pii: 00126334-990000000-00022.
    >> Share

  453. SIM MMS, Banerjee M, Myint T, Garvy BA, et al
    Total Plasma Protein S is a prothrombotic marker in People Living with HIV.
    J Acquir Immune Defic Syndr. 2022 Apr 4. pii: 00126334-990000000-00020.
    >> Share

  454. SALONER R, Savini N, Letendre SL, Moore DJ, et al
    Neopterin Relates to Lifetime Depression in Older Adults With HIV on Suppressive Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2022;89:454-461.
    >> Share

  455. LATHAM AH, Nissim OA, Spitznagel MC, Kirk SE, et al
    Impact of Integrase Strand Transfer Inhibitor Use During Pregnancy on Viral Suppression at Delivery and Infant Outcomes: A Statewide Retrospective Cohort Study.
    J Acquir Immune Defic Syndr. 2022;89:448-453.
    >> Share

  456. BENKI-NUGENT SF, Yunusa R, Mueni A, Laboso T, et al
    Lower Neurocognitive Functioning in HIV-Exposed Uninfected Children Compared With That in HIV-Unexposed Children.
    J Acquir Immune Defic Syndr. 2022;89:441-447.
    >> Share

  457. REMERA E, Nsanzimana S, Chammartin F, Semakula M, et al
    Brief Report: Active HIV Case Finding in the City of Kigali, Rwanda: Assessment of Voluntary Assisted Partner Notification Modalities to Detect Undiagnosed HIV Infections.
    J Acquir Immune Defic Syndr. 2022;89:423-427.
    >> Share

  458. KIM HN, Nance RM, Lo Re V 3rd, Silverberg MJ, et al
    Development and Validation of a Model for Prediction of End-Stage Liver Disease in People With HIV.
    J Acquir Immune Defic Syndr. 2022;89:396-404.
    >> Share

  459. MORRIS S, Cottrell M, Rawlings SA, Peterson S, et al
    Genital Inflammation Is Not Associated With Decreased Vaginal Tenofovir Concentrations in Women Taking Oral PrEP.
    J Acquir Immune Defic Syndr. 2022;89:390-395.
    >> Share

  460. JACOBSON EU, Hicks KA, Carrico J, Purcell DW, et al
    Optimizing HIV Prevention Efforts to Achieve EHE Incidence Targets.
    J Acquir Immune Defic Syndr. 2022;89:374-380.
    >> Share

  461. SHANGASE N, Edwards J, Pence B, Aiello A, et al
    Effect of Quality of Caregiver-Adolescent Relationship on Sexual Debut, Transactional Sex, and on Age-Disparate Relationships Among Young Women in Rural South Africa Enrolled in HPTN 068.
    J Acquir Immune Defic Syndr. 2022;89:366-373.
    >> Share

  462. CHAN CT, Ming K, Camp C, Saberi P, et al
    Sexual Behaviors, Substance Use, and Quality of Life Among Individuals Using PrEP in San Francisco During the COVID-19 Pandemic Shelter-In-Place Orders: A Cross-Sectional Survey.
    J Acquir Immune Defic Syndr. 2022;89:e39-e42.
    >> Share

  463. SALONER R, Lobo JD, Paolillo EW, Campbell LM, et al
    Cognitive and Physiologic Reserve Independently Relate to Superior Neurocognitive Abilities in Adults Aging with HIV.
    J Acquir Immune Defic Syndr. 2022 Apr 1. pii: 00126334-990000000-00016.
    >> Share

  464. SHAPIRO AE, Bender Ignacio RA, Whitney BM, Delaney JA, et al
    Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020.
    J Acquir Immune Defic Syndr. 2022 Apr 1. pii: 00126334-990000000-00019.
    >> Share

  465. BACHA JM, Dlamini S, Anabwani F, Gwimile J, et al
    Achieving antiretroviral therapy uptake and viral suppression among children and adolescents living with HIV in the UNAIDS 90-90-90 era across six countries in Eastern and Southern Africa - lessons from the BIPAI Network.
    J Acquir Immune Defic Syndr. 2022 Apr 1. pii: 00126334-990000000-00018.
    >> Share

  466. SHARPLESS L, Kershaw T, Hatcher A, Alexander KA, et al
    Intimate Partner Violence (IPV) and Patient-Provider Communication about HIV Pre-Exposure Prophylaxis (PrEP): The Moderating Role of IPV-Specific Medical Mistrust.
    J Acquir Immune Defic Syndr. 2022 Apr 1. pii: 00126334-990000000-00017.
    >> Share

    March 2022
  467. PATHELA P, Qasmieh S, Gandhi M, Rozen E, et al
    Use of remnant specimens to assess use of HIV pre-exposure prophylaxis (PrEP) among populations with risk for HIV infection: A novel approach.
    J Acquir Immune Defic Syndr. 2022 Mar 31. pii: 00126334-990000000-00015.
    >> Share

  468. BROWNE EN, Brown ER, Palanee-Phillips T, Reddy K, et al
    Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2022 Mar 28. pii: 00126334-990000000-00014.
    >> Share

  469. PSOMAS CK, Hoover DR, Shi Q, Brown TT, et al
    POLYPHARMACY IS ASSOCIATED WITH FALLS IN WOMEN WITH AND WITHOUT HIV.
    J Acquir Immune Defic Syndr. 2022 Mar 25. pii: 00126334-990000000-00013.
    >> Share

  470. WACHIRA J, Genberg B, Mwangi A, Chemutai D, et al
    Impact of an enhanced patient care (EPC) intervention on viral suppression among patients living with HIV in Kenya.
    J Acquir Immune Defic Syndr. 2022 Mar 23. pii: 00126334-990000000-00012.
    >> Share

  471. MENG W, Chen M, Song Y, Zhang H, et al
    Prevalence and Risk Factors of Low Bone Mineral Density in HIV/AIDS Patients: a Chinese Cross-sectional Study.
    J Acquir Immune Defic Syndr. 2022 Mar 22. pii: 00126334-990000000-00011.
    >> Share

  472. GOEDEL WC, Coats CS, Chan PA, Sims-Gomillia CE, et al
    A Pilot Study of a Patient Navigation Intervention to Improve HIV Pre-Exposure Prophylaxis Persistence Among Black/African American Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2022 Mar 21. pii: 00126334-990000000-00010.
    >> Share

  473. GEORGE G, Beckett S, Reddy T, Govender K, et al
    The role of schooling and comprehensive sexuality education in reducing HIV and pregnancy among adolescents in South Africa.
    J Acquir Immune Defic Syndr. 2022 Mar 18. pii: 00126334-990000000-00009.
    >> Share

  474. TAN Y, Zou S, Ming F, Zhang Z, et al
    Early efficacy and safety of the third dose inactivated COVID-19 vaccine among people living with HIV.
    J Acquir Immune Defic Syndr. 2022 Mar 17. pii: 00126334-990000000-00006.
    >> Share

  475. KUSEJKO K, Tschumi N, Chaudron SE, Nguyen H, et al
    Similar but different: Integrated phylogenetic analysis of Austrian and Swiss HIV-1 sequences reveal differences in transmission patterns of the local HIV-1 epidemics.
    J Acquir Immune Defic Syndr. 2022 Mar 17. pii: 00126334-990000000-00007.
    >> Share

  476. UNGER ZD, Golub SA, Borges C, Edelstein ZR, et al
    Reasons for PrEP Discontinuation Following Navigation at Sexual Health Clinics: Interactions among Systemic Barriers, Behavioral Relevance, and Medication Concerns.
    J Acquir Immune Defic Syndr. 2022 Mar 14. pii: 00126334-990000000-00005.
    >> Share

  477. IMBERT E, Hickey MD, Del Rosario JB, Conte M, et al
    Heterogeneous preferences for care engagement among people with HIV experiencing homelessness or unstable housing during the COVID-19 pandemic.
    J Acquir Immune Defic Syndr. 2022 Mar 9. pii: 00126334-990000000-00002.
    >> Share

  478. STOCKMAN J, Friedman J, Sundberg J, Harris E, et al
    Predictive analytics using machine learning to identify ART clients at health system level at greatest risk of treatment interruption in Mozambique and Nigeria.
    J Acquir Immune Defic Syndr. 2022 Mar 9. pii: 00126334-990000000-00001.
    >> Share

  479. RICE B, Machingura F, Maringwa G, Magutshwa S, et al
    Adolescent girls who sell sex in Zimbabwe: HIV risk, behaviours and service engagement.
    J Acquir Immune Defic Syndr. 2022 Mar 8. pii: 00126334-990000000-00003.
    >> Share

  480. SSEMPIJJA V, Nakigozi G, Ssekubugu R, Kagaayi J, et al
    HIGH RATE OF PRE-EXPOSURE PROPHYLAXIS (PrEP) ELIGIBILITY AND ASSOCIATED HIV INCIDENCE IN A POPULATION WITH A GENERALIZED HIV EPIDEMIC IN RAKAI, UGANDA.
    J Acquir Immune Defic Syndr. 2022 Mar 8. pii: 00126334-990000000-00004.
    >> Share

  481. PELUSO MJ, Williams MC, Campbell DM, Dee L, et al
    SARS-CoV-2 Booster Vaccination for Participants in "HIV Cure"-Related Clinical Trials.
    J Acquir Immune Defic Syndr. 2022;89:e30.
    >> Share

  482. BLOOMFIELD GS, Weir IR, Ribaudo HJ, Fitch KV, et al
    Prevalence and Correlates of Electrocardiographic Abnormalities in Adults With HIV: Insights From the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).
    J Acquir Immune Defic Syndr. 2022;89:349-359.
    >> Share

  483. WHITE DAE, Anderson ES, Basham K, Ng VL, et al
    Clinical Utility of the Signal-to-Cutoff Ratio of Reactive HIV Antigen/Antibody Screening Tests in Guiding Emergency Physician Management.
    J Acquir Immune Defic Syndr. 2022;89:332-339.
    >> Share

  484. FABIAN KE, Muanido A, Cumbe VFJ, Mukunta C, et al
    Integrating a Transdiagnostic Psychological Intervention Into Routine HIV Care: A Mixed-Methods Evaluation of the Common Elements Treatment Approach in Mozambique.
    J Acquir Immune Defic Syndr. 2022;89:274-281.
    >> Share

  485. HABERER JE, Mugo N, Bukusi EA, Ngure K, et al
    Understanding Pre-Exposure Prophylaxis Adherence in Young Women in Kenya.
    J Acquir Immune Defic Syndr. 2022;89:251-260.
    >> Share

    February 2022
  486. CLAY CE, Ling A, Bennett CL
    HIV Testing at Visits to United States Emergency Departments, 2018.
    J Acquir Immune Defic Syndr. 2022 Feb 28. pii: 00126334-900000000-95683.
    >> Share

  487. SAMBA BO, Lewis-Kulzer J, Odhiambo F, Juma E, et al
    Exploring Estimates and Reasons for Lost to Follow Up among People Living with HIV on Antiretroviral Therapy in Kisumu County, Kenya.
    J Acquir Immune Defic Syndr. 2022 Feb 24. pii: 00126334-900000000-95684.
    >> Share

  488. PARK LS, McGinnis KA, Gordon KS, Justice AC, et al
    SARS-CoV-2 testing and positivity among persons with and without HIV in 6 United States cohorts.
    J Acquir Immune Defic Syndr. 2022 Feb 21. pii: 00126334-900000000-95688.
    >> Share

  489. BROOKS KM, Pinilla M, Stek AM, Shapiro DE, et al
    Pharmacokinetics of tenofovir alafenamide with boosted protease inhibitors in pregnant and postpartum women living with HIV: Results from IMPAACT P1026s.
    J Acquir Immune Defic Syndr. 2022 Feb 21. pii: 00126334-900000000-95687.
    >> Share

  490. O'DONNELL MR, Padayatchi N, Wolf A, Zelnick J, et al
    Bedaquiline adherence measured by electronic dose monitoring predicts clinical outcomes in the treatment of patients with multidrug-resistant tuberculosis and HIV/AIDS.
    J Acquir Immune Defic Syndr. 2022 Feb 21. pii: 00126334-900000000-95686.
    >> Share

  491. NAKISIGE C, Adams SV, Namirembe C, Okoche L, et al
    Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living with HIV on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2022 Feb 21. pii: 00126334-900000000-95685.
    >> Share

  492. POURCHER V, Capeau J, Dudoit Y, Boccara F, et al
    Comparison of HIV-infected and non-infected patients undergoing bariatric surgery: the ObeVIH study.
    J Acquir Immune Defic Syndr. 2022 Feb 17. pii: 00126334-900000000-95689.
    >> Share

  493. SHUTER J, Chander G, Graham AL, Kim RS, et al
    A randomized trial of a web-based tobacco treatment and online community support for people with HIV attempting to quit smoking cigarettes.
    J Acquir Immune Defic Syndr. 2022 Feb 14. pii: 00126334-900000000-95691.
    >> Share

  494. ZHAO Y, Hohlfeld A, Namale P, Meintjes G, et al
    Risk of immune reconstitution inflammatory syndrome with integrase inhibitors versus other classes of antiretrovirals: a systematic review and meta-analysis of randomised trials.
    J Acquir Immune Defic Syndr. 2022 Feb 14. pii: 00126334-900000000-95690.
    >> Share

  495. CHAN C, Vaccher S, Fraser D, Grulich A, et al
    Incorrect knowledge of event-driven PrEP '2-1-1' dosing regimen among PrEP-experienced gay and bisexual men in Australia.
    J Acquir Immune Defic Syndr. 2022 Feb 7. pii: 00126334-900000000-95694.
    >> Share

  496. NIJHAWAN AE, Zhang S, Chansard M, Gao A, et al
    A Multicomponent Intervention to Reduce Readmissions Among People with HIV.
    J Acquir Immune Defic Syndr. 2022 Feb 7. pii: 00126334-900000000-95693.
    >> Share

  497. LI LJ, Tan P, Hee O, Agrawal R, et al
    Retinal Microvasculature And Immune Restoration Among South Eastern Asian HIV/AIDS Patients Over A 9-Month Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2022 Feb 7. pii: 00126334-900000000-95692.
    >> Share

  498. GOERLICH E, Schar M, Bagchi S, Soleimani-Fard A, et al
    Coronary endothelial dysfunction in people living with HIV is related to body fat distribution.
    J Acquir Immune Defic Syndr. 2022 Feb 4. pii: 00126334-900000000-95695.
    >> Share

  499. BOETTIGER DC, An VT, Kumarasamy N, Azwa I, et al
    Recent trends in adult and pediatric antiretroviral therapy monitoring and failure.
    J Acquir Immune Defic Syndr. 2022 Feb 3. pii: 00126334-900000000-95701.
    >> Share

  500. BAILIN SS, Gabriel CL, Fan R, Ye F, et al
    Relationship of Subcutaneous Adipose Tissue Inflammation-related Gene Expression with Ectopic Lipid Deposition in Persons with HIV.
    J Acquir Immune Defic Syndr. 2022 Feb 3. pii: 00126334-900000000-95700.
    >> Share

  501. SPOONER R, Ranasinghe S, Urasa S, Yoseph M, et al
    HIV-Associated Neurocognitive Disorders (HAND): The first longitudinal follow up of a cART-treated cohort of older people in sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2022 Feb 3. pii: 00126334-900000000-95699.
    >> Share

  502. HOFFMAN S, Zhang A, Nguyen N, Tsong R, et al
    Incident HIV Infection among Young Men Associated with Female Sexual Partner Types Identified Through Latent Class Analysis (LCA), Rakai, Uganda.
    J Acquir Immune Defic Syndr. 2022 Feb 3. pii: 00126334-900000000-95698.
    >> Share

  503. JOHNSON LF, Meyer-Rath G, Dorrington RE, Puren A, et al
    The effect of HIV programmes in South Africa on national HIV incidence trends, 2000-2019.
    J Acquir Immune Defic Syndr. 2022 Feb 3. pii: 00126334-900000000-95697.
    >> Share

  504. SELLERS SA, Edmonds A, Ramirez C, Cribbs SK, et al
    Optimal lung cancer screening criteria among persons living with HIV.
    J Acquir Immune Defic Syndr. 2022 Feb 3. pii: 00126334-900000000-95696.
    >> Share

  505. KALICHMAN SC, Eaton LA, Kalichman MO
    Believing that it is Hazardous to Mix Alcohol with Medicines Predicts Intentional Non-Adherence to Antiretrovirals.
    J Acquir Immune Defic Syndr. 2022 Feb 2. pii: 00126334-900000000-95702.
    >> Share

  506. GUARALDI G, Milic J, Barbieri S, Marchio T, et al
    Resilience and Frailty in People Living With HIV During the COVID Era: Two Complementary Constructs Associated With Health-Related Quality of Life.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  507. GHARE S, Singhal R, Bryant V, Gautam S, et al
    Age-Associated Gut Dysbiosis, Marked by Loss of Butyrogenic Potential, Correlates With Altered Plasma Tryptophan Metabolites in Older People Living With HIV.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  508. RINALDI S, Pallikkuth S, De Armas L, Richardson B, et al
    Distinct Molecular Signatures of Aging in Healthy and HIV-Infected Individuals.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  509. MASTERS MC, Landay AL, Robbins PD, Tchkonia T, et al
    Chronic HIV Infection and Aging: Application of a Geroscience-Guided Approach.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  510. ROUTY JP, Royston L, Isnard S
    Aging With Grace for People Living With HIV: Strategies to Overcome Leaky Gut and Cytomegalovirus Coinfection.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  511. FRASCA D, Pallikkuth S, Pahwa S
    Effects of Aging on Metabolic Characteristics of Human B Cells.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  512. TRAN T, Pencina KM, Schultz MB, Li Z, et al
    Reduced Levels of NAD in Skeletal Muscle and Increased Physiologic Frailty Are Associated With Viral Coinfection in Asymptomatic Middle-Aged Adults.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  513. CRANE HM, Drumright L
    HIV, Aging, and Comorbidities Research in Clinical Cohorts: 3 Lessons Learned Using Examples From the CNICS Cohort.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  514. MONTANO M, Landay A, Perkins M, Holstad M, et al
    HIV and Aging in the Era of ART and COVID-19: Symposium Overview.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  515. PALLIKKUTH S, Pahwa S
    HIV and Aging in the Era of ART and COVID-19.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

    January 2022
  516. DE ALMEIDA SM, Rotta I, Tang B, Umlauf A, et al
    Higher cerebrospinal fluid soluble urokinase-type plasminogen activator receptor, but not interferon gamma-inducible protein 10, correlate with higher working memory deficits.
    J Acquir Immune Defic Syndr. 2022 Jan 26. pii: 00126334-900000000-95706.
    >> Share

  517. EL BOUZIDI K, Murtala-Ibrahim F, Kwaghe V, Datir RP, et al
    Disengagement from HIV care and failure of second-line therapy in Nigeria: a retrospective cohort study, 2005-2017.
    J Acquir Immune Defic Syndr. 2022 Jan 26. pii: 00126334-900000000-95705.
    >> Share

  518. SUAREZ-GARCIA I, Ruiz-Alguero M, Alejos B, Garcia-Yubero C, et al
    Patients' experiences and opinions after de-simplification of their single-tablet regimens for the treatment of HIV infection: a survey in a multicentre cohort.
    J Acquir Immune Defic Syndr. 2022 Jan 26. pii: 00126334-900000000-95704.
    >> Share

  519. WHEATLEY MM, Knowlton G, Kao SY, Jenness SM, et al
    Cost-Effectiveness of Interventions to Improve HIV Pre-Exposure Prophylaxis Initiation, Adherence, and Persistence among Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2022 Jan 26. pii: 00126334-900000000-95703.
    >> Share

  520. WEI-MING WATSON C, Kamalyan L, Tang B, Hussain MA, et al
    Ethnic/Racial Disparities in Longitudinal Neurocognitive Decline in People with HIV.
    J Acquir Immune Defic Syndr. 2022 Jan 25. pii: 00126334-900000000-95707.
    >> Share

  521. GLANS M, Cooley SA, Vaida F, Boerwinkle A, et al
    Effects of Framingham 10-year cardiovascular risk score and viral load on brain integrity in persons with HIV.
    J Acquir Immune Defic Syndr. 2022 Jan 21. pii: 00126334-900000000-95709.
    >> Share

  522. LONG JE, Sanchez H, Dasgupta S, Huerta L, et al
    Self-reported knowledge of HIV status among cisgender male sex partners of transgender women in Lima, Peru.
    J Acquir Immune Defic Syndr. 2022 Jan 18. pii: 00126334-900000000-95711.
    >> Share

  523. YOUNG SD, Cumberland WG, Singh P, Coates T, et al
    A Peer-Led Online Community to Increase HIV Self-Testing among African American and Latinx MSM: A Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2022 Jan 18. pii: 00126334-900000000-95710.
    >> Share

  524. CHEN JS, Pettifor AE, Nelson JA, Phiri S, et al
    Blood and genital fluid viral load trajectories among treated and untreated persons with acute HIV infection in Malawi.
    J Acquir Immune Defic Syndr. 2022 Jan 17. pii: 00126334-900000000-95712.
    >> Share

  525. MOORE DM, Kremer H, Wang L, Lepik KJ, et al
    Evaluation of a public health referral system to re-engage individuals living with HIV who have interrupted antiretroviral therapy in British Columbia, Canada.
    J Acquir Immune Defic Syndr. 2022 Jan 10. pii: 00126334-900000000-95714.
    >> Share

  526. STARBUCK L, Golub SA, Klein A, Harris AB, et al
    Transgender Women and PrEP Care: High PrEP Adherence in a Real-World Health Care Setting in New York City.
    J Acquir Immune Defic Syndr. 2022 Jan 10. pii: 00126334-900000000-95713.
    >> Share

  527. DONENBERG GR, Fitts J, Ingabire C, Nsanzimana S, et al
    Results of the Kigali Imbereheza Project: A 2-arm individually randomized trial of TI-CBT enhanced to address ART adherence and mental health for Rwandan youth living with HIV.
    J Acquir Immune Defic Syndr. 2022 Jan 8. pii: 00126334-900000000-95715.
    >> Share

  528. TORDOFF DM, Zangeneh S, Khosropour CM, Glick SN, et al
    Geographic variation in HIV testing among transgender and non-binary adults in the US.
    J Acquir Immune Defic Syndr. 2022 Jan 7. pii: 00126334-900000000-95718.
    >> Share

  529. HILEMAN CO, Bowman ER, Gabriel J, Kettelhut A, et al
    Impact of Heroin and HIV on Gut Integrity and Immune Activation.
    J Acquir Immune Defic Syndr. 2022 Jan 7. pii: 00126334-900000000-95717.
    >> Share

  530. LUU BR, Nance RM, Delaney JAC, Ruderman SA, et al
    Insomnia and Risk of Myocardial Infarction Among People with HIV.
    J Acquir Immune Defic Syndr. 2022 Jan 6. pii: 00126334-900000000-95719.
    >> Share

  531. MAYER KH, Gelman M, Holmes J, Kraft J, et al
    Safety and Tolerability of Once Daily Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide for Post-Exposure Prophylaxis after Sexual Exposure.
    J Acquir Immune Defic Syndr. 2022 Jan 4. pii: 00126334-900000000-95720.
    >> Share

  532. ENDER PT, Markson RH, Suri A, Ruppert K, et al
    Rapid Implementation of a Telemedicine Program in a Ryan White-Funded HIV Clinic During a Global Pandemic.
    J Acquir Immune Defic Syndr. 2022;89:e2-e4.
    >> Share

  533. GAFF J, Estiasari R, Diafiri D, Halstrom S, et al
    Brief Report: Polymorphisms in CAMKK2 may Influence Domain-Specific Neurocognitive Function in HIV+ Indonesians Receiving ART.
    J Acquir Immune Defic Syndr. 2022;89:115-119.
    >> Share

  534. OUATTARA LA, Thurman AR, Jacot TA, Cottrell M, et al
    Genital Mucosal Drug Concentrations and anti-HIV Activity in Tenofovir-Based PrEP Products: Intravaginal Ring vs. Oral Administration.
    J Acquir Immune Defic Syndr. 2022;89:87-97.
    >> Share

  535. MEYER-MYKLESTAD MH, Medhus AW, Stiksrud B, Lorvik KB, et al
    Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum.
    J Acquir Immune Defic Syndr. 2022;89:77-86.
    >> Share

  536. ATTIA EF, Moraa H, Maleche-Obimbo E, Wamalwa D, et al
    Most Early-Treated Children With Perinatally Acquired HIV Have Preserved Lung Function at School Age.
    J Acquir Immune Defic Syndr. 2022;89:69-76.
    >> Share

  537. MBEWE EG, Kabundula PP, Mwanza-Kabaghe S, Buda A, et al
    Socioeconomic Status and Cognitive Function in Children With HIV: Evidence From the HIV-Associated Neurocognitive Disorders in Zambia (HANDZ) Study.
    J Acquir Immune Defic Syndr. 2022;89:56-63.
    >> Share

  538. RAGONNET-CRONIN M, Hayford C, D'Aquila R, Ma F, et al
    Forecasting HIV-1 Genetic Cluster Growth in Illinois,United States.
    J Acquir Immune Defic Syndr. 2022;89:49-55.
    >> Share

  539. MANN LM, Kelley CF, Siegler AJ, Stephenson R, et al
    Seroadaptive Strategy Patterns of Young Black Gay, Bisexual, and Other Men Who Have Sex With Men in Atlanta, Georgia.
    J Acquir Immune Defic Syndr. 2022;89:40-48.
    >> Share

  540. QIAN Y, Moore RD, Coburn SB, Davy-Mendez T, et al
    Association of the VACS Index With Hospitalization Among People With HIV in the NA-ACCORD.
    J Acquir Immune Defic Syndr. 2022;89:9-18.
    >> Share

  541. D'SOUZA G, Tong W, Gustafson D, Alcaide ML, et al
    SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study.
    J Acquir Immune Defic Syndr. 2022;89:1-8.
    >> Share

  542. PISCITELLI J, Nikanjam M, Best BM, Acosta E, et al
    Optimizing Dolutegravir Initiation in Neonates Using Population Pharmacokinetic Modeling and Simulation.
    J Acquir Immune Defic Syndr. 2022;89:108-114.
    >> Share

  543. LARSEN A, Abuna F, Owiti G, Kemunto V, et al
    Improving Quality of PrEP Counseling for Adolescent Girls and Young Women in Kenya With Standardized Patient Actors: A Dose-Response Analysis.
    J Acquir Immune Defic Syndr. 2022;89:34-39.
    >> Share

    December 2021
  544. DIJKSTRA S, Hofstra LM, Mudrikova T, Wensing AMJ, et al
    Lower incidence of HIV-1 blips observed during integrase inhibitor-based combination antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2021 Dec 24. pii: 00126334-900000000-95731.
    >> Share

  545. ARIMIDE DA, Amogne MD, Kebede Y, Balcha TT, et al
    High level of HIV drug resistance and virological non-suppression among female sex workers in Ethiopia: a nation-wide cross-sectional study.
    J Acquir Immune Defic Syndr. 2021 Dec 24. pii: 00126334-900000000-95730.
    >> Share

  546. JIANG H, Lan G, Zhu Q, Feng Y, et al
    Impacts Of HIV-1 Subtype Diversity on Long-Term Clinical Outcomes in Antiretroviral Therapy in Guangxi, China.
    J Acquir Immune Defic Syndr. 2021 Dec 24. pii: 00126334-900000000-95729.
    >> Share

  547. KILGORE CB, Strain JF, Nelson B, Cooley SA, et al
    Cardiorespiratory Fitness is Associated with Better White Matter Integrity in Persons Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Dec 24. pii: 00126334-900000000-95728.
    >> Share

  548. MUJUGIRA A, Nakyanzi A, Nabaggala MS, Muwonge TR, et al
    Effect of HIV Self-Testing on PrEP Adherence among Gender Diverse Sex Workers in Uganda: A Randomized Trial.
    J Acquir Immune Defic Syndr. 2021 Dec 23. pii: 00126334-900000000-95734.
    >> Share

  549. RIAL-CRESTELO D, Bisbal O, Font R, De Lagarde M, et al
    Incidence and severity of SARS-CoV-2 infection in HIV-infected individuals during the first year of the pandemic.
    J Acquir Immune Defic Syndr. 2021 Dec 23. pii: 00126334-900000000-95733.
    >> Share

  550. KING EM, Kaida A, Mayer U, Albert A, et al
    Undertreated midlife symptoms for women living with HIV linked to lack of menopause discussions with providers.
    J Acquir Immune Defic Syndr. 2021 Dec 23. pii: 00126334-900000000-95732.
    >> Share

  551. WANG Y, Karver TS, Barrington C, Donastorg Y, et al
    Structural and psychosocial impacts of the COVID-19 pandemic on HIV care and treatment outcomes among female sex workers in the Dominican Republic.
    J Acquir Immune Defic Syndr. 2021 Dec 21. pii: 00126334-900000000-95727.
    >> Share

  552. VIOLETTE LR, Cornelius-Hudson A, Snidarich M, Niemann LA, et al
    Evaluation of SAMBA II: a qualitative and semi-quantitative HIV point-of-care nucleic acid test.
    J Acquir Immune Defic Syndr. 2021 Dec 21. pii: 00126334-900000000-95726.
    >> Share

  553. GOLDEN MR, AugsJoost B, Bender M, Brady KA, et al
    The Organization, Content, and Case-finding Effectiveness of HIV Assisted Partner Services in High HIV Morbidity Areas of the U.S.
    J Acquir Immune Defic Syndr. 2021 Dec 21. pii: 00126334-900000000-95725.
    >> Share

  554. SACK DE, Gange SJ, Althoff KN, Pettit AC, et al
    Visualizing the geography of HIV observational cohorts with density-adjusted cartograms.
    J Acquir Immune Defic Syndr. 2021 Dec 21. pii: 00126334-900000000-95724.
    >> Share

  555. TAKUVA S, Karuna ST, Juraska M, Rudnicki E, et al
    Infusion reactions after receiving the broadly neutralizing antibody VRC01 or placebo to reduce HIV-1 acquisition: Results from the phase 2b Antibody Mediated Prevention (AMP) randomized trials.
    J Acquir Immune Defic Syndr. 2021 Dec 20. pii: 00126334-900000000-95735.
    >> Share

  556. HETTA G, Jane M, Michelle H, Anna D, et al
    Impact of HIV on Cognitive Performance in Professional Drivers.
    J Acquir Immune Defic Syndr. 2021 Dec 20. pii: 00126334-900000000-95723.
    >> Share

  557. KRENISKE P, Nalugoda F, Chen I, Huang R, et al
    Mobile phones, sexual behaviors and HIV incidence in Rakai, Uganda from 2010-2018.
    J Acquir Immune Defic Syndr. 2021 Dec 20. pii: 00126334-900000000-95721.
    >> Share

  558. WILSON EC, Turner CM, Sanz-Rodriguez C, Arayasirikul S, et al
    Expanding the Pie-Differentiated PrEP Delivery Models to Improve PrEP Uptake in the San Francisco Bay Area.
    J Acquir Immune Defic Syndr. 2021;88.
    >> Share

  559. SEVELIUS JM, Glidden DV, Deutsch M, Welborn L, et al
    Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California.
    J Acquir Immune Defic Syndr. 2021;88.
    >> Share

  560. RICE E, Wilder B, Onasch-Vera L, DiGuiseppi G, et al
    A Peer-Led, Artificial Intelligence-Augmented Social Network Intervention to Prevent HIV Among Youth Experiencing Homelessness.
    J Acquir Immune Defic Syndr. 2021;88.
    >> Share

  561. HOLLOWAY IW, Beltran R, Shah SV, Cordero L, et al
    Structural Syndemics and Antiretroviral Medication Adherence Among Black Sexual Minority Men Living With HIV.
    J Acquir Immune Defic Syndr. 2021;88.
    >> Share

  562. ARNOLD EA, Saberi P, Wong JO, Pollack LM, et al
    We are Family: A Feasibility and Acceptability Study of an HIV Prevention Intervention With the House Ball and Gay Family Communities.
    J Acquir Immune Defic Syndr. 2021;88.
    >> Share

  563. LIGHTFOOT M, Milburn N, Loeb Stanga L
    Addressing Health Disparities in HIV: Introduction to the Special Issue.
    J Acquir Immune Defic Syndr. 2021;88.
    >> Share

  564. LORENZ DR, Mukerji SS, Misra V, Uno H, et al
    Predictors of Transition to Frailty in Middle-Aged and Older People With HIV: A Prospective Cohort Study.
    J Acquir Immune Defic Syndr. 2021;88:518-527.
    >> Share

  565. SUPANAN R, Han WM, Harnpariphan W, Ueaphongsukkit T, et al
    Brief Report: HCV Universal Test-and-Treat With Direct Acting Antivirals for Prisoners With or Without HIV: A Prison Health Care Workers-Led Model for HCV Microelimination in Thailand.
    J Acquir Immune Defic Syndr. 2021;88:465-469.
    >> Share

  566. WAGNER Z, Mukasa B, Nakakande J, Stecher C, et al
    Impact of the COVID-19 Pandemic on Use of HIV Care, Antiretroviral Therapy Adherence, and Viral Suppression: An Observational Cohort Study From Uganda.
    J Acquir Immune Defic Syndr. 2021;88:448-456.
    >> Share

  567. FRIEDMAN MR, Kempf MC, Benning L, Adimora AA, et al
    Prevalence of COVID-19-Related Social Disruptions and Effects on Psychosocial Health in a Mixed-Serostatus Cohort of Men and Women.
    J Acquir Immune Defic Syndr. 2021;88:426-438.
    >> Share

  568. EKSTRAND ML, Heylen E, Gandhi M, Steward WT, et al
    COVID-19 Vaccine Hesitancy Among PLWH in South India: Implications for Vaccination Campaigns.
    J Acquir Immune Defic Syndr. 2021;88:421-425.
    >> Share

  569. LOPES J, Grimwood A, Ngorima-Mabhena N, Tiam A, et al
    Out-of-Facility Multimonth Dispensing of Antiretroviral Treatment: A Pooled Analysis Using Individual Patient Data From Cluster-Randomized Trials in Southern Africa.
    J Acquir Immune Defic Syndr. 2021;88:477-486.
    >> Share

  570. KANG M, Umbleja T, Ellsworth G, Aberg J, et al
    Effects of Sex, Existing Antibodies, and HIV-1 Related and Other Baseline Factors on Antibody Responses to Quadrivalent HPV Vaccine in Persons with HIV.
    J Acquir Immune Defic Syndr. 2021 Dec 14. pii: 00126334-900000000-95739.
    >> Share

  571. BEHRENS GMN, Aebi-Popp K, Babiker A
    Close to zero, but not zero: What is an acceptable HIV transmission risk through breastfeeding?
    J Acquir Immune Defic Syndr. 2021 Dec 10. pii: 00126334-900000000-95742.
    >> Share

  572. D'ANTONI ML, Andreatta K, Acosta R, Martin H, et al
    Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Efficacy in Participants with Pre-existing Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinical Trials.
    J Acquir Immune Defic Syndr. 2021 Dec 10. pii: 00126334-900000000-95741.
    >> Share

  573. GONZALES P, Bachireddy C, Grieco A, Ding R, et al
    Viral Suppression Levels in Newly Diagnosed Men Who Have Sex with Men and Transgender Women with Newly Diagnosed HIV and Alcohol Use Disorder in Peru: Results from a Randomized, Double-Blind, Placebo-Controlled Trial Using Oral Naltrexone.
    J Acquir Immune Defic Syndr. 2021 Dec 10. pii: 00126334-900000000-95740.
    >> Share

  574. ABUOGI LL, Castillo-Mancilla J, Hampanda K, Owuor K, et al
    Tenofovir Diphosphate in Dried Blood Spots in pregnant and postpartum women with HIV in Kenya: a novel approach to measuring peripartum adherence.
    J Acquir Immune Defic Syndr. 2021 Dec 9. pii: 00126334-900000000-95743.
    >> Share

  575. TITANJI BK, Tejani M, Farber EW, Mehta CC, et al
    Cognitively-Based Compassion Training for HIV Immune Non-responders - An Attention-Placebo Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2021 Dec 7. pii: 00126334-900000000-95752.
    >> Share

  576. BIEN-GUND CH, Bilker W, Schnoll RA, Tyndale RF, et al
    Nicotine metabolism ratio increases in HIV-positive smokers on effective antiretroviral therapy: a cohort study.
    J Acquir Immune Defic Syndr. 2021 Dec 7. pii: 00126334-900000000-95751.
    >> Share

  577. BEKKER A, Rabie H, Salvadori N, du Toit S, et al
    Pharmacokinetics and safety of the abacavir/lamivudine/lopinavir/ritonavir fixed-dose granule formulation (4-in-1) in neonates: PETITE study.
    J Acquir Immune Defic Syndr. 2021 Dec 2. pii: 00126334-900000000-95754.
    >> Share

  578. BATES L, Honeycutt A, Bass S, Green TA, et al
    Updated Estimates of the Number of Men Who Have Sex With Men (MSM) With Indications for HIV Pre-exposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2021;88:e28-e30.
    >> Share

  579. KOAY WLA, Prabhakar S, Neilan A, Meyers J, et al
    Brief Report: Supporting Access to HIV Care for Children and Youth During the COVID-19 Pandemic With Telemedicine and Rideshare.
    J Acquir Immune Defic Syndr. 2021;88:384-388.
    >> Share

  580. REES H, Chersich MF, Munthali RJ, Brumskine W, et al
    HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use.
    J Acquir Immune Defic Syndr. 2021;88:376-383.
    >> Share

    November 2021
  581. GROVES AK, Bhushan NL, Stoner MCD, Gomez-Olive FX, et al
    HIV and HSV-2 incidence among Adolescent Mothers in South Africa: A Longitudinal Analysis of HIV Prevention Trials Network 068 Data.
    J Acquir Immune Defic Syndr. 2021 Nov 25. pii: 00126334-900000000-95755.
    >> Share

  582. CARLUCCI JG, De Schacht C, Graves E, Gonzalez P, et al
    CD4 Trends with Evolving Treatment Initiation Policies among Children Living with HIV in Zambezia Province, Mozambique, 2012-2018.
    J Acquir Immune Defic Syndr. 2021 Nov 24. pii: 00126334-900000000-95758.
    >> Share

  583. DONG T, Rana MN, Longenecker CT, Rajagopalan S, et al
    Machine Learning Estimation of Low-Density Lipoprotein Cholesterol in Women with and without HIV.
    J Acquir Immune Defic Syndr. 2021 Nov 22. pii: 00126334-900000000-95759.
    >> Share

  584. CHAI PR, Mohamed Y, Bustamante MJ, Goodman GR, et al
    DigiPrEP: A pilot trial to evaluate the feasibility, acceptability, and accuracy of a digital pill system to measure PrEP adherence in men who have sex with men who use substances.
    J Acquir Immune Defic Syndr. 2021 Nov 8. pii: 00126334-900000000-95762.
    >> Share

  585. CAPOFERRI AA, Redd AD, Gocke CD, Clark LR, et al
    Rebound HIV viremia with meningoencephalitis following antiretroviral therapy interruption after allogeneic bone marrow transplant.
    J Acquir Immune Defic Syndr. 2021 Nov 8. pii: 00126334-900000000-95761.
    >> Share

  586. CALZA L, Legnani G, Fulgaro C, Verucchi G, et al
    CHANGES IN SERUM INFLAMMATORY MARKERS IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED PATIENTS STARTING DOLUTEGRAVIR/LAMIVUDINE OR DOLUTEGRAVIR/LAMIVUDINE/ABACAVIR.
    J Acquir Immune Defic Syndr. 2021 Nov 5. pii: 00126334-900000000-95763.
    >> Share

  587. FONG Y, Markby J, Andreotti M, Beck I, et al
    Diagnostic accuracy of dried plasma spot specimens for HIV-1 viral load testing: a systematic review and meta-analysis.
    J Acquir Immune Defic Syndr. 2021 Nov 2. pii: 00126334-900000000-95767.
    >> Share

  588. OPOLLO V, Nyakeriga E, Kingwara L, Sila A, et al
    Evaluation of the Performance of OraQuick(R) Rapid HIV-1/2 Test among decedents in Kisumu, Kenya.
    J Acquir Immune Defic Syndr. 2021 Nov 2. pii: 00126334-900000000-95766.
    >> Share

  589. MOMPER JD, Wang J, Stek A, Shapiro DE, et al
    Pharmacokinetics of atazanavir boosted with cobicistat in pregnant and postpartum women with HIV.
    J Acquir Immune Defic Syndr. 2021 Nov 2. pii: 00126334-900000000-95765.
    >> Share

  590. MATTHEWS RP, Jackson Rudd D, Zhang S, Fillgrove KL, et al
    Safety and Pharmacokinetics of Once-Daily Multiple-Dose Administration of Islatravir in Adults Without HIV.
    J Acquir Immune Defic Syndr. 2021;88:314-321.
    >> Share

  591. GIACOMELLI A, Bonazzetti C, Conti F, Pezzati L, et al
    Brief Report: Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic.
    J Acquir Immune Defic Syndr. 2021;88:299-304.
    >> Share

  592. KATUREEBE C, Ashburn K, Machekano R, Gill MM, et al
    Developing and Validating an Effective Pediatric and Adolescent HIV Testing Eligibility Screening Tool for High-Volume Entry Points in Uganda.
    J Acquir Immune Defic Syndr. 2021;88:290-298.
    >> Share

  593. ZHU W, Huang YA, Kourtis AP, Hoover KW, et al
    Trends in the Number and Characteristics of HIV Pre-Exposure Prophylaxis Providers in the United States, 2014-2019.
    J Acquir Immune Defic Syndr. 2021;88:282-289.
    >> Share

  594. DAUBERT E, French AL, Burgess HJ, Sharma A, et al
    Association of poor sleep with depressive and anxiety symptoms by HIV disease status: Women's Interagency HIV Study (WIHS).
    J Acquir Immune Defic Syndr. 2021 Nov 1. pii: 00126334-900000000-95764.
    >> Share

    October 2021
  595. HOJILLA JC, Hurley LB, Marcus JL, Satre DD, et al
    The HIV preexposure prophylaxis (PrEP) continuum of care among transgender individuals in an integrated healthcare system.
    J Acquir Immune Defic Syndr. 2021 Oct 28. pii: 00126334-900000000-95770.
    >> Share

  596. SAXBY K, Chan C, Bavinton BR
    Structural stigma and sexual health disparities among gay, bisexual, and other men who have sex with men in Australia.
    J Acquir Immune Defic Syndr. 2021 Oct 28. pii: 00126334-900000000-95769.
    >> Share

  597. NYANDIKO W, Holland S, Vreeman R, DeLong AK, et al
    HIV-1 Treatment Failure, Drug Resistance and Clinical Outcomes in Perinatally-Infected Children and Adolescents Failing 1st-Line Antiretroviral Therapy in Western Kenya.
    J Acquir Immune Defic Syndr. 2021 Oct 28. pii: 00126334-900000000-95768.
    >> Share

  598. GIBBS A, Reddy T, Closson K, Cawood C, et al
    Intimate partner violence and the HIV care and treatment cascade among adolescent girls and young women in DREAMS, South Africa.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95776.
    >> Share

  599. ZANG X, Mah C, Linh Quan AM, Min JE, et al
    Human Immunodeficiency Virus transmission by HIV risk group and along the HIV care continuum: A contrast of six US cities.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95775.
    >> Share

  600. SYED MA, Khan A, Chaudhry A, Baig MA, et al
    An Epidemic of Pediatric HIV from Reuse of Infusion Equipment in Pakistan.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95774.
    >> Share

  601. VOLPE LJ, Powis KM, Legbedze J, Sun S, et al
    A counseling and monitoring approach for supporting breastfeeding women living with HIV in Botswana.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95773.
    >> Share

  602. CONROY AA, Jain JP, Sheira L, Frongillo EA, et al
    Mental Health Mediates the Association between Gender-Based Violence and HIV Treatment Engagement in U.S. Women.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95772.
    >> Share

  603. SUEN LW, Davidson PJ, Browne EN, Lambdin BH, et al
    Effect of an Unsanctioned Safe Consumption Site in the United States on Syringe Sharing, Rushed Injections, and Isolated Injection Drug Use: A Longitudinal Cohort Analysis.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95771.
    >> Share

  604. NANYONGA SM, Kitutu FE, Kalyango J, Frank M, et al
    High burden of adverse drug reactions to Isoniazid Preventive Therapy in people living with HIV at three tertiary hospitals in Uganda: associated factors.
    J Acquir Immune Defic Syndr. 2021 Oct 21. pii: 00126334-900000000-95777.
    >> Share

  605. ROUSSEAU RK, Walmsley SL, Lee T, Rosenes R, et al
    A randomized, blinded, placebo-controlled trial of De Simone formulation probiotic during HIV-associated suboptimal CD4+ T cell recovery.
    J Acquir Immune Defic Syndr. 2021 Oct 20. pii: 00126334-900000000-95779.
    >> Share

  606. SHAFFER D, Kumwenda J, Chen H, Akelo V, et al
    Brief Report: No Differences Between Lopinavir/ritonavir and non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)
    J Acquir Immune Defic Syndr. 2021 Oct 19. pii: 00126334-900000000-95780.
    >> Share

  607. SAHAGUN SJ, Yeramosu T, Purdy JB, Reynolds JC, et al
    Associations between Central Obesity and Life-Long Antiviral Therapy in Adults Living with HIV Acquired from Early Childhood.
    J Acquir Immune Defic Syndr. 2021 Oct 19. pii: 00126334-900000000-95778.
    >> Share

  608. SCHURMANN D, Rudd DJ, Schaeffer A, De Lepeleire I, et al
    Single oral doses of MK-8507, a novel non-nucleoside reverse transcriptase inhibitor, suppress HIV-1 RNA for a week.
    J Acquir Immune Defic Syndr. 2021 Oct 13. pii: 00126334-900000000-95781.
    >> Share

  609. PYRA M, Brewer R, Rusie L, Kline J, et al
    Long-term HIV Pre-exposure Prophylaxis Trajectories Among Racial & Ethnic Minority Patients: Short, Declining, & Sustained Adherence.
    J Acquir Immune Defic Syndr. 2021 Oct 9. pii: 00126334-900000000-95782.
    >> Share

  610. LONGINO AA, Paul R, Wang Y, Lama JR, et al
    HIV disease dynamics, markers of inflammation and CNS injury during primary HIV infection and their relationship to cognitive performance.
    J Acquir Immune Defic Syndr. 2021 Oct 7. pii: 00126334-900000000-95788.
    >> Share

  611. TRUJILLO L, Robbins T, Morris E, Sionean C, et al
    Material hardship and association with sexual risk behavior among adolescent sexual minority males in 3 U.S. cities - National HIV Behavioral Surveillance-Young Men who Have Sex with Men, 2015.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95789.
    >> Share

  612. KAPLAN SR, Escudero JN, Mecha J, Richardson BA, et al
    Interferon gamma release-assay and tuberculin skin test performance in pregnant women living with and without HIV.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95787.
    >> Share

  613. DIAZ RS, Grangeiro A, Estevam DL, Galinskas J, et al
    Pre-exposure prophylaxis failure with a multiple drug-resistant HIV-1 clade C virus in Brazil.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95786.
    >> Share

  614. FAZELI PL, Woods SP, Lambert CC, Li W, et al
    Differential Associations Between BDNF and Memory Across Older Black and White Adults with HIV Disease.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95784.
    >> Share

  615. HELLER T, Wallrauch C, Gumulira J, Rambiki K, et al
    Low CD4 counts despite effective ART in hospitalized Malawian HIV+/COVID+ co-infected patients.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95783.
    >> Share

  616. GROV C, Patel VV, D'Angelo AB, Zohra F, et al
    Close, But Not Quite: One in Twenty Trans and Gender Diverse Individuals Assigned Female at Birth Are Being Prescribed the Wrong Kind of PrEP.
    J Acquir Immune Defic Syndr. 2021;88:e10-e11.
    >> Share

  617. VICTOR O, Phiona M, Vernon M, Thoko M, et al
    Adverse Event Trends Within a Large-Scale, Routine, Voluntary Medical Male Circumcision Program in Zimbabwe, 2014-2019.
    J Acquir Immune Defic Syndr. 2021;88:173-180.
    >> Share

    September 2021
  618. ERLY S, Khosropour CM, Hajat A, Sharma M, et al
    Characterization of the Population Impacted by the 6-Month Recertification Criterion of the Ryan White HIV/AIDS Program's AIDS Drug Assistance Program in Washington State, 2017-2019.
    J Acquir Immune Defic Syndr. 2021 Sep 30. pii: 00126334-900000000-95790.
    >> Share

  619. CICCULLO A, D'Angelillo A, Iannone V, Farinacci D, et al
    Real-Life Safety of Doravirine in Treatment-Experienced, Virologically Suppressed PLWHIV.
    J Acquir Immune Defic Syndr. 2021;88:e5-e6.
    >> Share

    August 2021
  620. BIRX D, Zaidi I
    Forward: Measuring Progress Toward Epidemic Control.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  621. MISHRA A, Mshweshwe-Pakela N, Kubeka G, Hansoti B, et al
    Systems Analysis to Increase HIV Testing Delivery and HIV Diagnosis in Primary Care Clinics in South Africa.
    J Acquir Immune Defic Syndr. 2021;87:1048-1054.
    >> Share

  622. BAVINTON BR, Vaccher S, Jin F, Prestage GP, et al
    High Levels of Prevention-Effective Adherence to HIV PrEP: An Analysis of Substudy Data From the EPIC-NSW Trial.
    J Acquir Immune Defic Syndr. 2021;87:1040-1047.
    >> Share

  623. CORNELISSE VJ, Traeger MW, Wright EJ, Murphy D, et al
    Brief Report: Low Incidence of Hepatitis C Among a Cohort of HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP) in Melbourne, Australia, and the Contribution of Sexual Transmission.
    J Acquir Immune Defic Syndr. 2021;87:1011-1015.
    >> Share

  624. OKERE NE, Lennox L, Urlings L, Ford N, et al
    Exploring Sustainability in the Era of Differentiated HIV Service Delivery in Sub-Saharan Africa: A Systematic Review.
    J Acquir Immune Defic Syndr. 2021;87:1055-1071.
    >> Share

    July 2021
  625. KOUSARI A, Moser C, Olefsky M, Brown TT, et al
    Poorer Muscle Quality and Quantity with ART Initiation is Associated with Greater Inflammation and Immune Activation.
    J Acquir Immune Defic Syndr. 2021 Jul 28. pii: 00126334-900000000-95835.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016